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SECTION I. 
GENERAL INTROLUCTION. 
The presence of a hormone -like principle in the 
corpus luteum was suspected following the observations 
made by Fraenkel -in 1903 upon the effect of ablation 
of the corpus luteum of pregnancy. _i correlation 
between the activity of the corpus luteum and histolo- 
:gical changes in the uterus had been suggested by 
Bouin and Ancel (1909, 1911) and Meyer (1911), but it 
was not until 1928 that the active principle of the 
corpus luteum was clearly demonstrated by Corner and 
Allen and the term "progestational" aoplied to its 
effect u-oon the endómetrium. 
In the following year, a saturated dihydroxy 
alcohol was isolated from human pregnancy urine by 
Iviarrian (1929) and although progesterone itself was 
not to be isolated and identified until 1934 and the 
biochemical significance of this new compound could 
not be foreseen, its discovery marked the beginning of 
a new phase in the study of the corpus luteum hormone. 
The structural relationship of this substance to the 
bile acids was established by Butenandt (1931) and the 
new steroid was naffed "pregnanediol ". 
In 1934 the isolation of progesterone was reported 
almost simultaneously by Butenandt, Westphal and Hohlwe 
;flotta, Ruschig and Fels; Allen and `:;intersteiner; and 
Hartmann and Wettstein, and following the elucidation 
of its structure by Butenandt et al. (1934) 
>; 
ii. 
the possibility that pregnanediol might be a metabolic 
reduction product of progesterone in the body became 
apparent. 
The isolation of allopregnanediol frum human 
pregnancy urine by Hartman and. Locher (1935) appeared 
to lend support to this hypothesis although it may be 
stated in parenthesis that conclusive evidence that 
allopregnanediol is a metabolite of progesterone is 
still awaited. 
In 1936, yenning and Browne demonstrated the con - 
of glucuronic acid 
:jugation of pregnanediol as a sodium salt/in pregnancy 
urine and in the following year yenning (1937) develop -d 
a method for the determination of ,pregnanediol glucur- 
:onìde in urine. Using this method, yenning and 
Browne (1937, 1938, 1940) studied the excretion of 
urinary pregnanediol in normal pregnancy, in the 
menstrual cycle, and in a series of investigations in 
which progesterone was administered to human subjects. 
These important studies which established `oregnane 
:diol as a metabolic product of progesterone, form the 
essential basis for further investigations such as are 
envisaged in the present work. These workers sugges- 
ted that the uterine endometrium was involved in the 
metabolic reduction of progesterone to pregnanediol, 
that the pregnanediol so formed was conjugated with 
glucuronic acid in the liver, and that the glucuronide 
was excreted by the kidney. A study of the literature 
however, reveals the paucity of evidence referable to 
the intermediary metabolism of progesterone and the 
conflicting nature of existing observations. 
It must be admitted therefore that, at the present 
time very little is known concerning the biochemical 
processes involved in the .metabolic reduction of 
progesterone to pregnanediol; concerning the part 
played by any organ or tissue in that conversion and 
concerning the factors which determine the metabolism 
of progesterone under physiological conditions. 
The isolation ofprgnanololie and allopregnanolone 
by Marker et al (1937) and the establishment of 
pregnanolone glucuronide as a metabolic product of 
progesterone by Dorfman, Ross & Shipley (1948) have 
raised new problems - technical and theoretical - which 
complicate the interpretation of the results of 
previous studies upon the metabolism of progesterone. 
The rationale of an attempt to develop an 
improved method for pregnanediol determination and of 
the necessity to reinvestigate many of the observation 
of Vennin and Browne and others, are discussed, along 
with details of previous work on the metabolism of 
progesterone, in the relevant introductory sections 
throughout the thesis. 
The main objectives of the present work were as 
follows: - 
(1) The development of a method for the 
quantitative determination of small amounts 
of pregnanediol in human urine. 
Specificity was considered as essential as 
accuracy. As it was intended to carry out 
determinations daily and in duplicate, and 
coincident determinations of other urinary 
steroids when desired, it was necessary that 
the method should be rapid and convenient 
and that not more than one quarter or one 
fifth of a twenty -four hour s >ecimen of urin 
should be emloyed in a single determination. 
(2) The application of such a method to the 
excretion of urinary pregnanediol in human 
subjects. It was considered that priority 
should be given to studies which might throw 
some light upon the intermediary metabolism 
of progesterone rather than to clinical 













QUANTITATIVE DETERMINATION of PREGANEDIOL in 
HUMAN URINE. 
Introduction. 
(a) Methods for the determination of pregnanediol as 
ifs glucuronide. 
It may be stated at the outset that no method 
has been evolved for the Quantitative determination of 
sodium pregnanediol glucuronidate, but several methods 
have been described for the determination of the 
glucuronides of pregnanediol -like substances. The 
most widely employed of such methods is that of Yenning 
(1937, 1938), and it is to this method that we are 
indebted for almost all the observations on the 
excretion of urinary pregnanediol which have been 
made during the last decade. This method is however 
open to criticism on the grounds of lack of specificity. 
It has been shown by Marrian and Gough (1946) that the 
final product by this method contains only about 80 
of the pure sodium pregnanediol glucuronidate and that 
the remaining 20% is largely composed of such ketonic 
glucuronides as sodium pregnanolone glucuronidate 
(Sutherland and Marrian (1946,1947). Apart from 
lack of specificity, the Yenning method is time- consum- 
:ing and laborious and a reasonable degree of accurary 
is not achieved when the method is applied to urines 
containing amounts of pregnanediol less than about 
10 - 15 mg. /24 hr. specimen. At these low levels of 
excretion the identity of the final product becomes 
2. 
even less certain as larger volumes of urine must be 
extracted to yield a measurable amount of glucuronide. 
A serious disadvantage which ap -plies to all 
methods for the determination of pregnanediol as its 
glucuronide (Allen and Viergiver, 1941, Jayle, Crepy 
and Wolf, 1943, Bisset, Brooksbank and Haslewood, 1947) 
is the fact that hydrolysis of the glucuronide and 
liberation of the free pregnanediol readily occur as 
a result of bacterial action in the urine. yenning 
(1938) stresses the importance of refrigeration of 
specimens and states that hydrolysis will occur at 
room temperature even in the presence of such preserva- 
:tives as tricresol, toluene, or chloroform. Bisset, 
Brooksbank and Haslewood (1947) who describe an 
entrainment procedure for the determination of a 
pregnanediol -like glucuronide (PLG), advocate 
refrigeration at 0 - 5° during collection followed by 
immediate analysis. 
This disadvantage creates yet another 
potential source of error and justifies a somewhat 
sceptical approach to reports of low or irregular 
excretions of urinary pregnanediol as determined by 
these methods. On the other hand the labour 
involved in obtaining specimens under these conditions 
might well be justified by results, should a more 
specific method for the determination of pregnanediol 
as its glucuronide be evolved. 
3. 
(2) Methods for the determination of pregnanediol 
aft-6i. acid -hydrolysis of its glucuronide. 
In 1941, Astwood and Jones described a 
method for the determination of the free form of 
pregnanediol which consisted essentially of the 
following steps: - 
(i) liberation of free pregnanediol by acid 
hydrolysis. 
(ii) extraction of the free pregnanediol 
with toluene. 
(iii),separation of impurities from the toluene 
extract by precipitation with methanolic 
sodium hydroxide solution. 
(iv) purification of the pregnanediol in the 
toluene extract by precipitation from 
ethanolic solution with four volumes. of 
dilute sodium hydroxide solution of water. 
In a series of recovery experiments in 
which , "sodium pregnanediol glucuronidate "was added 
to male urine, Astwood and Jones obtained an average 
yield of 68- with amounts of pregnanediol greater 
than about 2mg. /litre. 
Talbot, Berman, MacLachian and Wolfe (1941) 
increased the sensitivity of this method by estimating 
the purified pregnanediol colorimetrically in terms 
of the yellow colour which it yields with concentrated 
sulphuric acid. These workers obtained recoveries 
similar to those of Astwood and Jones in a short 
series of experiments. One litre of urine was 
required for a single determination by either method. 
As has been stated above, the "sodium 
pregnanediol glucuronidate" used by these workers 
contained only about 80 of pure sodium pregnanediol 
glucuronidate and their results must therefore have 
been rather higher than they themselves reported 
but in our experience the combined Astwood- Talbot 
procedure did not give accurate or reproducible results 
when applied to urines containing less than 10mg./24 
urine volume. 
It seemed possible however that by certain 
modifications in this procedure and by rigid standard H 
:isation of technique, the degree of accuracy might be 
increased to include these important lower levels of 
pregnanediol excretion. (Guterman (1944) described 
a qualitative method for the detection cá' impure 
pregnanediol, based on the procedure of Atwood and 
Jones as modified by Talbot et al. This and other 
semi -quantitative simplifications of the original 
procedures will be discussed in Section S.) 
A colorimetric method for the estimation 
of pregnanediol based upon interaction with acetyl 
chloride and zone chloride in glacial acetic acid 
solution has been described recently by Goldzieher 
(1948). Such a reaction has been used previously 
for the determination of the blood cholesterol (Rose, 
Schattner. and Exton, 1941). The procedure prior to 
colorimetry is more troublesome and time- consuming 
than that described by Talbot et al and although data 
regarding the degree of specificity is not submitted, 
the fact that the reaction can be utilised for the 
determination of cholesterol is not encouraging. 
After very numerous preliminary experiments 
the following modifications were made in the Astwood- 
Talbot procedure by Dr Nancy Gough and Prof. G.P. 
Marrian;- 
(i) Washing the toluene extract with aqueous 
sodium hydroxide was found to be a simpler 
method of removing acidic and phenolic 
substance than the boiling and precipitation 
by methanolic sodium hydroxide advocated by Ì 
A stwood and Jones (1941) . 
(ii) In recovery experiments in which pure 
pregnane -3 (c.) , 20c.ß. -diol was added to the 
neutral toluene- soluble fraction of acid - 
hydrolysed male urine, satisfactory male 
urine blanks and im ?roved recoveries of 
pregnanediol were obtained when the 
precipitation was carried out by dissolving 
the neutral fraction from 1/5 of a 24hr. 
specimen in 4m1. ethanol and precipitating 
with 16m1.11/10 sodium hydroxide on one 
occasion and with water on two subsequent 
occasions. 
(iii) To facilitate the quantitative collection 
of the pregnanediol precipitated and to 
avoid as far as possible transference of 
material from vessel to vessel, the 
precipitation was carried out in centrifuge 
tubes and the precipitate collected by 
centrifugation instead of filtration. 
(iv) It was found that a blue pigment probably 
of dietary origin which occasionally 
contaminated the final product could be 
removed without loss of pregnanediol by 
warming in ethanolic solution with charcoal. 
This treatment with charcoal was adopted 
as a routine to maintain uniformity of 
procedure and formed an essential part of 
the procedure in later work. (Section 111). 
In experiments carried out after these 
modifications had been adopted, recoveries of 89,fl or 
higher were invariably obtained when more than about 
4 mg. of pregnanediol were present in 1/5 of a 24 hr. 
specimen of urine. With smaller amounts of 
pregnanediol the recoveries were lower and often 
very irregular. 
This marked irregularity suggested that 
some variable in the purification process was not 
being properly controlled. 
1. Standardisation of conditions during 
thé precipit ion óf- t-he pregnanediol 
from hot ethanolic solution. 
The temperature conditions at the time of 
precipitation of the pregnanediol from ethanolic 
solution are not accurately defined in the original 
procedure of Astwood and Jones, and have found rather 
differing interpretations by subsequent workers. 
(i) Astwood and Jones (1941): The neural residue is 
completely dissolved in 10m1. of 95 ethanol by 
heating and while the heating is continued, 40m1 of 
hot aqueous O.1N, sodium hydroxide solution is added 
slowly. The flash is allowed to stand at room 
temperature until cold and then placed in a refriger- 
:ator overnight. 
(ii) Talbot, Berman, Macbachlan and Wolfe (1941): The 
neutral residue is dissolved in 10m1. absolute ethanol 
by heating on a water bath and while heating is 
continued, 40m1. aqueous 0.1 N. sodium hydroxide is 
added slowly and the flask placed in a refrigerator 
overnight. 
(iii). Guterman (1944,1945): 5 c.c. acetone (the 
change of solvent will be discussed later)is added to 
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the residue and the mixture is warmed over a hot plate 
until solution is complete, 20 c.c. 0.1 N. sodium 
hydroxide is added while the mixture is still on the 
hot plate. The flask is then _ù laced in an ice -water 
bath for 60 minutes or in a rerrigerator (5 °C) for 
one hour. 
Other workers have favoured conditions 
selected from the above, for example Wheatley and 
Maclagan (1948) precipitate from acetone and cool to 
room temperature. 
It seemed probable that recoveries would be 
improved by the mere replacement of such terms as "hot" 
and "room temperature" by standardised . conditions. 
(i) Temperature during addition of N /10 sodium hydroxide 
-solution or water. 
It was apparent that a temperature of the order of 
75 °C was necessary to ensure complete solution of the 
crude nregnanediol in the toluene - soluble residue. 
This temperature could be maintained at the time of 
adding the N/10 sodium hydroxide solution in the 
following manner; the centrifuge tube containing 
4.0m1. othanol was placed in a Veaker containing water 
which was maintained for four minutes at 75 °C. After 
one minute, the 16.0 ml. of N /10 sodium hydroxide were 
added drop by drop from a burette during 3 minutes 
with stirring, the last 1 ml. being used to wash down 
the stirring rod into the tube. Beaker and contents 
were then maintained at 75 °C for a further minute. 
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(ii) Rate of cooling of the hot precipitation mixture: 
The question now arose whether the precipitation 
mixture should be allowed to cool rapidly or slowly. 
To ,allow it to cool to room temperature would not be 
consistent with a desire for a uniform technique since 
this would constitute fairly rapid cooling in a 
Scottish laboratory in winter -time but might approximate 
to slow cooling at other times and in.,other laboratories. 
In addition it seemed possible that the size of 
the crystals or precipitated aggregates might be 
determined by the rate of cooling so that by slow 
cooling, larger particles might be produced, centrifug- 
:ation made more efficient, and loss of pregnanediol 
in the supernatant solution considerably reduced. 
A preliminary investigation of this possibility 
was carried out as follows: 
(a) Pure pregnane- 3(c0,200( diol was prepared from 
human pregnancy urine and purified by Prof. 
Marrian via its diacetate (m.p. 236 - 237° 
corr.) . 
(b) The toluene- soluble neutral fraction of acid - 
hydrolysed pooled male urine, which was 
employed in this and other preliminary 
experiments, was prepared by.the following 
procedure: the pooled urine was heated to 
boiling together with one -fifth of its volume 
of toluene (B.F. sulphur -free, redistilled) 
acidified with one -tenth of its volume of 
concentrated hydrochloric acid (A.R.) and 
boiling continued for 10 minutes. After 
cooling, the mixture was extracted three 
times with one -fifth volumes of toluene, 
emulsions being broken by filtration through 
Buchner funnel with gentle suction. The 
combined toluene extracts were washed twice 
with one -fifth volume of N. sodium hydroxide, 
three times with one -fifth volumes of water, 
evaporated to a small volume (ca. 30 c.c.) and 
finally taken to dryness under reduced 
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pressure in the water -bath. The dark 
reddish -brown gummy material will be referred 
to as "neutral fraction male urine" (N. F. hr. U.) . 
In the recovery experiments to be described, 
an aliqot portion of this N. F.I. U. re_Dresenting 500 c. c. 
of pooled male urine was added to each centrifuge tube, 
pregnane -3(000,20d diol in ethanol added to a variable 
number of tubes while the remaining tubes containing 
only ITT. I+'. M. U. acted as "male urine blanks ". It was 
absolutely essential that these "blanks" should, after 
the triple precipitation procedure, yield a very small 
amount of final product with a very low degree of 
chromogenicity in the sulphuric acid reaction. 
In this experiment two series of tubes were 
compared in both of which the ,precipitation mixture 
was at a temperature of 75 °C after addition of the N /id 
sodium hydroxide solution by the procedure described 
above. In one series the mixture was cooled rapidly 
by immersion of the tube in an ice -bath and transfer - 
:ence to a refrigerator where it was left overnight 
before centrifugation. In a second series the tubes 
were allowed to stand in the beakers at the laboratory 
temperature (15 °C), until (after 22 hours) the temper - 
:ature of the mixture had fallen from 75 °C to 18 °C 
when the beakers were transferred to the refrigerator 
and left overnight before centrifugation. 
These latter conditions did not constitute 
a very slow rate of cooling of the precipitation 
mixture but none the less the result upon she recovery 









a 0.00 0.05 10.0 
al 0.00 0.07 14.0 
b 0.50 0.09 17.0 
b1 0.50 0.13 25.1 
b2 0.50 0.04 8.0 




c 0.00 0.03 6.0 
c1 0.00 0.03 5.5 
d 0.50 0.35 70.2 
dl 0.50 0.26 55.5 





If the apparent pregnanediol recovery be 
corrected for the average male urine blank for each 
series the corrected recovery by Rapid Cooling is 
4.5% and by Slow Cooling, 58.2%. This difference of 
over 50% in the recovery of pregnanediol at this level 
can only be accounted for by the difference in the 
rate of cooling of the precipitation mixture. Various 
methods of slow cooling were investigated and the 
following proved a satisfactory and simple procedure 
independent of laboratory temperature. The tube 
containing the mixture and surrounded by water in a 
250 c.c. beaker at a temperature of 75 °C was transferr- 
:ed immediately to an incubator at 37 °C. The 
temperature of the mixture fell to 37 °C in ca. two 
hours and the beaker was then transferred to a 
refrigerator when further cooling to 00 - 5° occurred 
overnight. 
Until this time, overnight refrigeration had 
been repeated after the 2nd and 3rd precipitations and 
it now seemed possible that this time - consuming 
procedure might be eliminated by substituting two 
shorter periods of slow cooling in the incubator. 
A comparison was therefore made between two 
series of tubes: 
Procedure A : 2Z hours slow cooling after the 
2nd and 3rd precipitations in 
incubator followed by j hour in 
refrigerator. 
11. 
Procedure B: 4 hours slow cooling after the 
2nd and 3rd orecipitations. 
(Centrifugation did not cause a detectable rise in the 
temperature of the mixture). The results are shown 


















0.51 0.352 0.453 0.436 86.2 
0.51 0.351 0.452 0.435 86.2 
0.00 0.021 0.028 - OEM 
B. 
4 hours 0.00 0.020 0.027 - 
0.51 0.311 0.400 0.372 73.6 
0.51 0.306 0.398 0.370 73.5 





CONCLUSION: 22 hours slow cooling after the 2nd 
and 3rd precipitations was not detrimental to the 
recovery of pregnanediol. Because of this fact it 
became possible to shorten the time taken for each 
determination from four days to two days. The second 
day however was inconveniently long (10 hours). 
12. 
If the time of centrifugation could be 
reduced to one hour on each occasion then a more 
convenient eight hour working day would be possible and 
accordingly attempts were made to improve the conditions 
of sedimentation 
Attempts to improve sedimentation by filter aids: 
Despite centrifugation for two hours at a 
speed of 1500 r.p.m. (centrifuge head of radius 15 cm. 
difficulty was experienced in obtaining adequate 
packing down of the relatively light pregnanddiol 
crystals and although a fine bore glass suction tube 
with fine terminal hook was used to syphon off the 
supernatant solution, some loss was suspected by this 
route. In addition was suspected crystals 
held on the surface of the mixture by surface tension. 
(a) Charcoal. 
It was thought that some heavy absorbent subh 
as charcoal might improve sedimentation and at the sane 
time absorb some of the urinary pigments responsible 
for the male urine blank. This in fact occurred but 
on the addition of ethanol prior to filtering off the 
charcoal, this pigment - normally eliminated by the 
triple pptn. process, - was eluted out of the charcoal 
giving a wine colouration to the ethanol solution. 
(b) "Cetavlon ". 
This detergent was investigated with a view to 
reducing surface tension and preliminary results were 
encouraging but as is shown in Table 3 it was not as 
13. 
efficient as artificial filter aids and the fact that 
the latter gave better results when used alone than 
when used along with "Cetavlon" suggested that the 
detergent might in fact have a slightly detrimental 
effect by dissolving small amounts of pregnanediol 
which would otherwise have been dragged down by the 
filter aid. 
(c) "Hyflo -Super Cel ". 
A fine spatula -point of this inert diatomaceous 
earth was added to the mixture immediately prior to 
centrifugation. As is shown in Table 3 and again in 
Table 4, this modification was probably an important 
step towards the elimination of that occasional low 
recovery which had been a feature of the method up to 
this time. In tubes b, bl, and b2 in Table 3 the 
recovery depended largely on how much of the precipitate 
adhered to the sides of the centrifuge tubes and this 
obviously could not be relied upon. The fact that 
greatly improved recoveries at low levels of pregnane- 
:diol resulting from slow cooling of the precipitation 
mixture in two of the tubes in the first series in 
Table 3 could still be obtained in the absence of 
filter aid makes it seem unlikely that the cooling 
effect could be explained on the basis that these 
inert particles acting as nuclei, favour the formation 
of larger aggregates of the p:- ecipitated material. 
A filter aid of finer particle size was 






















0.404 ' 80.6 
0.51 b1) 0.363 0.445 0.434 86.5 
0.51 b2) 0.102 0.127 0.116 24.5 
Hyf10 0.00 0.060 0.075 - - 
Super 0.00 0.052 0.065 - - 
Cel. 
0.51 0.340 0.422 0.352 68.6 
0.51 0.471 0.582 0.512 99.8 
0.51 0.438 0.545 0..=75 92.5 
TABLE 4. 
Procedure. Pregnane- Spekker. Pregnane- ;fl 




A2parent : Corr. 
Hyflo 
0.00 0.0.45 0.055 - - 
S per 0.00 0.027 0.035 - - 
Cel. 0.52 0.426 0.502 0.457 88.5 
0.52 0.350 0.415 0.670 71.2 
0.00 0. 03 2 0.040 - - 
Hyflo 0.00 0.030 0.036 - - 
Super Cel 0.52 0.311 0.365 0.3271 62.9 plus 
Cetavlon 
0.52 0.421 0.449 0.411 79.0 
14. 
material of the N.F.M.U. other than pregnanediol and 
defeated the purpose of the repeated precipitations. 
(iv) Attempt to shorten time of centrifugation: 
With improved sedimentation it now seemed 
possible that centrifugation for one hour at 1500 r. p.ml. 
might suffice. In a series of experiments in which 
0.504 mg. of pregnane -3 (d) , 20- diol was added to 
N. F. M. U. (Table 5) , it was found that the second hour 
which had previously been essential was now redundant, 
the time taken for one determination was therefore 
reduced by three hours and the second day of the 
method became a convenient length (eight hours). 
(v) Comparison of Rapid Coolingánd Slow Cooling 
when varying amounts of _pregnanediol are 
ädded to N.F.M.U. 
At this stage in the evolution of the method, 
a series of experiments were carried out with the 
object of confirming the importance of the rate of 
cooling of the precipitation mixture upon the recovery 
of pregnanediol and of investigating this effect at 
various levels of pregrianediol. 
The N.F.M.U. was prepared in the manner 
already described but pooled 24hr. urine specimens 
from five healthy males were used in place of pooled 
male urine. Two batches of urine, (A & B) were worke 
up in this way comprising a total of forty five lots 
of N.F.M.U. each of which was equivalent to one -fifth. 
of a single 24 hr. specimen. Two solutions of pure 
pregnane -3(cß) , 20d -diol were prepared. 
Table 5. 
Procedure. Pregnane- 
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(i) 6.648 mg. in 25 ml. ethanol. 
(ii) 40.010 mg. in 50 ml. ethanol. 
The results of this series of recovery experiments 
are given in Table 6. 
CONCLUSION: Rapid cooling of the precipitation 
mixture gave lower and much more irregular results than 
were obtained by the slow -cooling technique. This 
difference in recovery due to the rate of cooling was 
most marked at levels below 0.53mg. Above this level 
rapid cooling tended to result in the production of 
occasional low recoveries. Between 0.40 mg. and 0.27 
mg. there appeared to be a critical level below which 
recoveries by either procedure would be poor. Attempts 
were therefore made to lower this level with the 
possibility in mind that this might be achieved by 
still tower rate of cooling. Since the procedures of 
Talbot et al. and Guterman undoubtedly involved rapid 
1 
cooling it may be concluded that such procedures would ì 
be liable to give low and erratic results with urines 
containing less than ca. 20 mg. of pregnanediol per 
24 hr. 
(vi) Attempt to eliminate refrigeration even at a 
low pregnanediol level. 
An attempt was made to investigate the effect 
of slow cooling on a level intermediate between 0.4 mg - 
where recovery in the previous.experiments was good. - 
and 0.25 mg. where recovery was very bad. Accordingly 
0.322 mg. of pure pregnane- 3(á),20d diol was added to 
Table 6. 
The effect of varying the rate of coolin, after 
precipitation on the recovery of pregnanediol added to 
"male urine neutral fraction". 
Male Pregnane- 
Urine diol. 




0 pregnanediol re- 
covered corrected 









































0.017d' 0.040 - - 
0.015 ó 0.042 ó - - 
0.010)6 0.037ó á 
0.032 2 0.123 )co ) 0 
0.012 0.092)S 
0.025 0 0.0726 
0.016) 0.33) 
0.021)0 0.38 1 




























tubes containing N.r.M.U. prepared from pooled 24 hr. 
specimens from four healthy males. At the same time 
an attempt was made to eliminate the used the 
refrigerator. in the procedure. 
Procedure 1 as in previous experiment, with 
overnight refrigeration after 1st pptn. 
and 2 hr. refrig. after incubation 
following 2nd and 3rd pptns. 
Procedure 2 incubation overnight after 1st and 
3rd pptns and incubation for two hours 
after 2nd pptn. 
Results: 
TABLE 7. 
Method Pregnand- Spekker. Pregnanediol 
diol added recovered 

















0.220 0.280 0.256 79.6 
0.245 0.318 0.294 91.4 
av. 
0.201 0.258 0.234 72.78h.2 
0.262 0.340 0.316 98.2 
av. 
0.260 0.338 0.3141 97.5 97.9. 
CONCLUSION: It was possible to eliminate refrigera- 
:tion and achieve a satisfactory recovery at this low 
level by the procedure described. Recoveries by the. 
17. 
same procedure were very poor at the slightly lower 
level of 0.25 mg. and could not be improved by slower 
cooling in the temperature range 75° to 55 °C. This 
confirmed the impression that a critical level exists 
apparently between 0.25 and 0.35 mg. per one -fifth of a 
24 hr. specimen. This may constitute a critical 
ratio between N.F.M.U. ethanolic solution and the 
pregnanediol ethanolic solution used in the recovery 
experiments. Below this level the pregnanediol may be 
held in solution due to a preponderance of some factor 
in the pigmented gummy neutral residue. If this is 
so it might be assumed that the quantitative recovery 
of pregnanediol in pure solution would be _possible belon 
this level. 
(vii) Recovery .of pure pregnane -3 (c) , 20(dß) -diol in 
pure solution. 
Pregnanediol solution: 9.810 mg. in 50 ml. 
ethanol. 
Procedure: Procedure 2 of previous experi- 
:ment. 
Results are given in Table 8. Reagent "blanks" 
were not included in this experiment, but 20 ml. of the 
purified ethanol used was evaporated to dryness and 
found to have no chromogenic power when tested in the 
sulphuric acid reaction. 
CONCLUSION: With careful technique a very small and 
relatively constant loss (0.01 mg.) occurs in precipi -. 












0.098 0.062 0.080 81.5 0.021 
0.098 0.075 0.093 95.0 0.005 
0.196 0.152 0.180 92.0 0.016 
0.196 0.160 0.190 97.0 0.006 
0.294 0.252 0.295 100.0 - 
0.294 0.245 0.287 97.6 0.007 
0.392 0.327 0.381 97.5 0.011 











(viii) Further attempts to shorten the method: 
(a) Centrifugation at 1500 r.p.m. for 30 minutes as 
shown in Table 9. This gave quite satisfactory 
results in this type of experiment but the results wer 
less satisfactory in urines containing large amounts 
of pregnanediol as in late pregnancy. 
(b) Filtration by porcelaid Filter Stick. This 
appeared to offer a possible method of filtration of 
the precipitation mixture which would not involve 
transference. from vessel to vessel. The precipitation 
was carried out in short 1" diameter boiling tubes. 
A filter stick was chosen of a porosity which appeared 
to resist the passage of pregnanediol brecipilated out 
of pure solution. Very low recoveries were obtained, 
however, when this was applied to the precipitate in 
the presence of N. F. v4. U. This effect appeared to 
depend to some extent upon the alkalinity of the 
Precipitation mixture and the success or failure of the 
procedure appeared to depend too much upon the nature 
of the neutral residue of the urine investigated. 
(c) A one -day method was possible if each pptn. was 
followed by 2 hrs. incubation and 30 minutes centrifug- 
:ation. Redoveries were 10= lower by this method than 
by the previous one, but the results were encouraging 
for future work on a short method suitable for clinical 
use. On the other hand, as shown in Table 9, no 
detrimental effect was apparent after prolonged 
19. 
incubation of the pptn. mixture - in this case at least 
16 hours at 37 °after each precipitation. This series 
of experiments again illustrates the excellent recovery 
at levels just above the critical level. 
(ix) Recovery experiments to illustrate the impor- 
tance of three pptns. in the purification 
process. 
One precipitation only is employed in the 
Guterman modification of the Astwood- Talbot procedures. 
After centrifugation of the recipitation mixture in 
the present series of experiments, the precipitate 
was usually a pale brown colour due to the sedimenta- 
tion and adsorption of highly chromogenic material of 
the N. F. Y. U. Two series of tubes were compared as 
shown in Table 10. 
CONCLUSION: At least two precipitations are essential 
to ensure reasonable blank readings and very high 
blank readings make it impossible to estimate the 
per centage recovery of added pregnanediol. The 
effect on the male urine blanks may be summarised as 
follows : - 
Male Urine Blanks. 
3 pptns. (1xN /10 NaOH; 2 x Water) i pptn (1xN /1p 
OH) 
0.02 mg. 0.33 mg. 
0.01 mg. 0.27 mg. 
0.02 mg. 0.37 mg. 
ay. gives an apparent pregnanediol content of :- 







Present 0.39 0.352 
technique 0.39 0.336 
0.39 0.360 
Centrifug 0.39 0.330 
30 min x 3. 0.39 0.339 
0.39 0.342 
Incubation 0.39 0.302 
2 hr after 0.39 0.296 
1st pptn. 
Prolonged 0.39 0.350 
incubation 0.39 0.345 
0.39 0.335 
Pregnane- 
diol Re- Recovery 
c:overed mg. 
A;l..parent : Corr. 























Headings as above. 
Present 0.00 
technique: 0.00. 











































0.768 216.0 151.6 
0.401 143.8 79.4 
20. 
This finding would afford a reasonable 
explanation for the many false positive results which 
have been obtained when the Guterman test was used for 
the diagnosis of pregnancy. It is only fair to add 
however that filtration and not centrifugation is 
employed in the Guterman procedure and by choice of a 
filter of suitable porosity quite low blanks might be 
obtained although this would incur a proportionately 
higher loss of pregnanediol,(unless large crystals be 
produced by a slow cooling of the precipitation 
mixture - see Section III). 
A more important disadvantage of the 
omission of the 2nd and 3rd pptns would almost certain 
:ly be lack of specificity due to incomplete elimina- 
tion of steroids other than pregnanediol which give 
a yellow colour with sulphuric acid. The specificity 
of the method ::gas investigated in some detail (q.v.) 
(x) Choice of solvent for pregnanediol in the 
precipitation process. 
Although Astwood and Jones and Talbot et al. 
used ethanol in the precipitation process, Guterman 
and others who have followed him with qualitative or 
semi- quantitative simplifications of the Astwood -Jones 
procedures substituted acetone for this purpose. 
(Mack and Parks, 1947; Wheatley & Maclagan, 1948). 
In view of the marked difference in the solubility of 
pregnanediol in ethanol and acetone, it could not be 
assumed that the precipitation procedure described by 
21. 
Astwood and Jones would be satisfactory when acetone 
was substituted for ethanol. Furthermore, after a 
paper had been read to the Society for Endocrinology 
upon the effect of slow cooling of the precipitation 
mixture upon the recovery of pregnanediol (Somerville, 
Gough and Marrian, 1947) several workers suggested the 
application of this technique to the Guterman metLca, 
or to one of its modifications. 
It by no means followed that the temperature 
difference which has been proved in the series of 
recovery ex ,eriments reported above (Table 6), where 
ethanol was used as the solvent, would be found to the 
same extent in the case of acetone. 
Three series of tubes with appropriate "blanks" 
were compared as shown in Table 11. The rapid cooling 
technique consisted of immediate transference of the 
tube containing the precipitati on mixture to an ice - 
bath as in the original experiments. Precipitation 
from acetone was carried out at 65° (the acebne was 
not dried) . 
CONCLUSION: At this level of pregnanediol - 0.4 mg./ 
one -fifth of a 24 hr specimen, the slow cooling 
technique gave excellent recoveries using ethanol. 
Either rate of cooling gave very poor recoveries with 
acetone. 
The acetone was purified by refluxing with 
potassium permanganate and then twice redistilled over 











Acetone 0.00 0.023 0.023 
Rapid 0.00 0.025 0.025 
Cooling. 0.40 0.022 0.022 
0.40 0.056 0.060 0.036 9.0 
0.40 0.041 0.045 0.021 5.3 
Acetone 0.00 0.012 0.012 
Slow 0.00 0.010 0.010 
Cooling 0.40 0.155 0.160 0.149 37.3 
0.40 0.130 0.135 0.124 31.0 
0.40 0.195 0.200 0.189 47.2 
Ethanol 0.00 0.016 0.016 
Slow 0.00 0.011 0.011 
Cooling. 0.40 0.384 0.384 0.375 93.8 
0.40 0.398 0.398 0.389 97.3 
0.40 0.367 0.367 0.358 89.5 
22. 
To exclude the possibility that the purified 
acetone contained permanganate or other contaminant 
destructive to pregnanediol, two additional tubes were 
carried through the method using unpurified Acetonum 
B.P. and similar low recoveries were obtained. 
A more satisfactory investigation of the effec 
of the choice of solvent in the Guterman and allied 
procedures, will be obtained by using the same volume 
ratios in the precipitati ng mixture, but it will be 
impossible to duplicate the less well defined 
temperature conditions. 
Method finally adopted for the determination of 
Pregnanediol, in Urine. 
Quickfit and Quartz glassware, with inter- 
changeable standard glass joints, was used throughout 
in order to avoid contamination of the urinary extracts 
with coloured or chromogenic material that might be 
dissolved out of rubber or cork stoppers. The 
toluene was B.'. "sulphur free" and was redistilled 
before use. Ethanol was purified by refluxing for 
six hours with solid sodium hydroxide and then twice 
redistilled over a glass column containing glass beads.) 
A 24 hr. specimen of urine collected with 5 ml. of 
toluene as preservative is made up to 2500 ml. and 
duplicate 500 ml. samples removed. Each sample is 
treated as follows: It is placed in a 1000 ml. flask 
and after the addition of 100 ml. of toluene 
brought to 
boiling point under a reflux condenser. To 
the 
23. 
boiling mixture is added down the condenser 50 ml. of 
concentrated hydrochloric acid (A.R.) and the boiling 
continued for exactly 10 min. The flask is then 
rapidly cooled in cold water and the contents trans- 
ferred to a separating funnel of 750 ml. capacity. 
After shaking and allowing the urine layer to separate, 
the latter is run off into the original flask and the 
layer of toluene and emulsion filtered with gentle 
suction through a Whatman No. i paper on a Buchner 
filter funnel. The urine layer is then returned to 
the separating funnel and extracted twice more with 
100 ml. portions of toluene, each toluene and emulsion 
layer being filtered in succession through the same 
filter funnel. The combined filtrates are then 
transferred to a clean separating funnel, and after 
running off the small urine layer that separates, the 
toluene extract is washed twice with 100 ml. portions 
of N sodium hydroxide and twice with 100 ml. portions 
of water. The washed toluene extract is run into a 
500 ml. round- bottomed flask and is evaporated nearly 
to dryness on an electric hot plate and then taken 
completely to dryness under reduced pressure on a 
boiling -water bath. 
The dry residue is transferred quantitatively 
with war ethanol to a 20 ml. conical centrifuge tube 
and the ethanolic solution evaporated to dryness in a 
water -bath under a stream of air. To the residue in 
the tube are added exactly 4.0 ml. of ethanol and the 
24. 
tube is placed in a beaker of water maintained at 75 °. 
After stirring with a glass rod for i min. to obtain 
complete solution, 16.0 ml. of N /10 sodium hydroxide are 
added drop -wise from a burette during 3 min. with 
stirring, the last 1 ml. being used to wash down the 
stirring rod into the tube. After a further 1 min. 
at 75 °, the beaker Of water containing the, tube is 
transferred to an incubator at 37° and left overnight. 
Approximately 8 -10 mg of 'Hyflo -Super Cel' (Johns - 
Manville Co. Ltd.) are added'and the mixture stirred 
with a glass rod. The rod is washed down into the 
tube with i ml. of a 1 : 4 (v /v) ethanol -water mixture 
and the tube is then centrifuged for 1 hr. (1500 r.p.m; 
radius of centrifuge head: 15 cm.). The supernatant 
solution is finally sucked 'from the precipitate with 
the aid of a fine glass tube attached to a slowly 
running water -jump. 
The second and third precipitations are carrie 
out as described above, except that Water instead of 
sodium hydroxide solution is used, and the incubation 
periods are reduced for convenience to 2 hr. No 
additional filter -aid is added before the centrifuga- 
:tions following the second and third precipitations. 
To the final precipitate are added 5 ml. of 
ethanol and the pregnanediol dissolved by warming with 
stirring at about 75 °. 'ktorite' charcoal (c. 1 -2 mg.) 
is then added and the warming continued for 2 min. 
The mixture is filtered through a small filter 
25. 
(Whatman No. 1 paper) into a test -tube of 1 in. 
diameter, the centrifuge tube and filter being washed 
three times with 2 ml. portions of warm ethanol. The 
filtrate and washings in the tube are evaporated in a 
water -bath under a stream of air and the residue finally 
dried by leaving the tube in a vacuum desiccator over 
calcium chloride for several hours. 
The colour reaction is carried out with not 
more than ca. 0.5 mg. of the finally purified product. 
If, therefore, the amount of the latter appears on 
inspection to be in excess of 0.5 mg. a suitable aliquot 
portion is removed after solution in a known volume 
of ethanol. To the dry pregnanediol 10.0 ml. of 
concentrated sulphuric acid (A.R.) are added from a 
burette, and the tube is left in a water -bath at 25° 
for 20 min. with occasional shaking. The intensity 
of the yellow colour produced is measured in a 'Spekker' 
photoelectric absorptiometer using a 'spectrum violet' 
No. 601 light filter. 
The absorptiometer readings are interpreted by 
reference to a calibration curve made with known 
amounts of pure pregnane -3(d), 20d -diol varying from 
0.1 to 0.5 mg. It is advisable to construct a fresh 
calibration curve for each batch of unknowns. 
(xii) Investigation of accuracy of the method finally 
adopted. 
The accuracy of the method was tested in a series 
of experiments in which pure sodium pregnanediol 
26. 
glucuronidate was added in varying amounts to the 
urine of healthy male subjects. The validity of such 
tests depends on two assumptions: (a) that all the 
pregnanediol in human urine is excreted as the glucur- 
:onide, and (b) that women's urine contains no 
substances which are not present in men's urine which 
would interfere with the determination of pregnanediol. 
No evidence contrary to these assumptions exists at 
the present time. 
Sodium pregnane- 3(d.), 20 oC --diol glucuronidate 
was prepared from human glucuronides by the method of 
yenning and Browne (1936) and freed from ketonic 
glucuronides by the method of Sutherland & Marrian 
(1946, 1947). The preparation used in the recovery 
experiments melted at 282 -283° (corr.) with decomposi-' 
i 
:tion and evolution of gas. Samples of the glucuroni= 
:date were weighed out after exposure to moist air. 
As shown by Sutherland & Marrian (1947) material so 
treated is the trihydrate having the composition 
C27H4308Na. 3H20. 
Twelve 24 hr. specimens of urine were collected 
from four normal men. Each specimen was made up to 
2500 ml. and four 500 ml. samples removed. To each 
of two of these samples was added an identical amount 
of sodium pregnanediol glucuronidate dissolved in 80.; 
ethanol, the other two samples being retained for 
working up as male urine "blanks ". All four samples 
from each specimen were then treated as described 
in 
27. 
Section xi. The results are summarised in Table 12. 
CONCLUSION: High regular recoveries of the order of 
9 5. are obtained above levels corresponding to 1.0 mg./ 
500 ml. At the 0.4 mg. level, the critical effect 
due to the presence of pigments or gummy fractions of 
the N? . M. U. is just apparent. In view of the small 
loss entailed in hydrolysis and extraction and the 
results of the previous recovery series Table 6, it 
seems justifiable to assume that the range of high 
regular recoveries extends down to a level of ca. 0.5 
mg. /500 ml. and of satisfactory duplicate determination. 
to ca. 0.4 mg. /500 ml. The concentration of the 
inimicable factör in the N. F. Li. U. in each specimen 
under consideration will determine the ó recovery 
below this level. 
Table 12. 
Recovery of pregnanediol after the addition of sodium 
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SPECIFICITY of the METHOD FINALLY ADOPTED. 
Introduction. 
The importance of attempting to assess the 
specificity of any method in which the final product 
is determined by the sulphuric acid reaction lies in 
the fact that many other steroids, many of which are 
present in human urine give similar colours to 
pregnanediol in this reaction. The specificity of 
the method described above must therefore depend upon 
the completeness with which other chromogenic steroids 
originally present in the urine are eliminated in the 
extraction and purification process. 
Previous work: 
(a) Astwood and Jones (1941): Using a double 
precipitation process, these workers showed that 
cholesterol and androsterone were completely 
elininated when present in pure solution in 
amounts not exceeding 16 rng. and 8 mg. respect- 
ively. 
(b) Talbot, Berman, iiacLachlan and Wolfe (1941) : 
The results cb tained by these workers who also 
used a double precipitation process suggested 
that no interference resulted from amounts of 
dehydroisoandrosterone in amounts up to ca. 10 mg. 
per litre. This was' an important observation 
in view of the intense chromogenicity of this 
compound in the sulphuric acid reaction. 
29. 
(c) Dr Nancy Gough, in this laboratory, has investigat 
the behaviour of an ethanolic solution of 
pregnane - d,) , 17, 20 -triol in the :urification 
process. This steroid was readily eliminated and 
in any case, it would be largely decomposed during 
the initial hydrolysis of the urine with acid 
which thus affords an additional safeguard against 
interference. 
In the present work, the behaviour of the 
following steriods in the triple precipitation process 
has been investigated using ethanolic solutions of 
the pure compounds. 
(1) ANDROSTERONE: Androstan- 3(d.) -o1 -17 -one. 
Amounts of androsterone corresponding to 1.0, 
2.0, 4.0, and 8.0 mg /500 c. c. were added to 
duplicate centrifuge tubes and the three 
'precipitations and charcoal filtration carried 
out as in the method. 
Standard solutions: 
(a) Pure androstan- 3(cß.) -o1 -17 -one. 
40.062 mg. in 20 ml. ethanol. 
m.p.: 181 - 182 G (corr) . 
(b) Pure pregnane -3(cL), 20d. -dìol. 
2.496 mg. in 10 ml. ethanol. 
u e 





tube. ;p ekke r . Mg. Recov. as. 
pregnanediol 
/500 ml. 
Iv_g. Recov. as 
androsterone 
/500 ml. 
1.0 a. 0.024 0.237 0.25 
1.0 ( 5. 0/24hr. ) a. 0.032 0.035 0.35 
2.0 b 0.039 0.045 0.40 
2. 0(10. 0/24hr) b 0.028 0.032 0.30 
4.0 c 0.056 0.066 0.62 
4.0(20.0/24hr) cl 0.094 0. 115 0.98 
8.0 d 0.250 0.624 5.24 
8. 0 ( 40 . 0/24hr ) dl 0.292 0.730 6.16 
( 1:2 ) 
COTNNCLUSION: Satisfactory elimination of amounts of 
androsterone less than ca. 20 mg /24 hr. is obtained. 
Amounts of more than 20 - 30 mg. are unlikely to be 
found even in pathological conditions in man. A 
comparison of the calibration curves indicates that 
pregnanediol is ten times more chromogenic than 
androsterone in the sulphuric acid reaction. This 
fact contributes to the specificity of the method and 
constitutes an advantage of colorometric methods over 
gravimetric methods. 
(2) ISOANDROSTERONE: Andrdstan- 3(13) -o1 -17 -one. 
The procedure was the same as in the Previous 
experiment. 
Standard solution: Pure ah róstan -3(p) -01-17 -one. 
m.p. 1720 - 1740 (corr.) 




Tube. Sp ekke r . 
Mg.Recovd. Mg.Recovd. 











































CONCLUSION: Precipitation during incubation was 
slightly less complete than in the case of androsterone 
and occurred at temperahires below 37° so that crystals 
were visible in the supernatant even after centrifuga- 
tion. The results were however very similar to those 
obtained with androsterone and this steroid is unlikely 
to interfere with the specificity of the method. 
Pregnanediol is approximately eight times more chromo- 
:genic than isoandrosterone. 
(3) Dehydroisoandrosterone: 
Procedure as in the previous experiment. 
Standard solution of the pure compound (ex acetate 













1.0 j 0.020 0.022 0.045 
1.0 jl 0.032 0.035 0.080 
2.0 k 0.026 0.030 0.070 
2.0 k1 0.035 0.040 0.085 
4.0 1 0.036 0.040 0.085 
4.0 11 
, 0.038 0.045 0.098. 
8.0 m 0.030 0.036 0.082 
8.0 m1 0.056 0.065 0.145 
CONCLUSION: Dehydroisoandrosterone is more 
powerfully chromogenic than the two previous compounds 
having approximately one -half of the chromógenicity 
of pregnanediol and it is providential that it is so 
completely eliminated in the precipitation process. 
The presence of dehydroisoandrosterone alone in the 
urine should not lead to an appreciable apparent 
pregnanediol recovery. 
(4) Pregnanolone : Pregnan-3(d)-01-20-one. 
Pure pregnan- 30) -o1 -20 -one prepared by the 
method of Sutherland and Marrian (19:1..6,1947) from the 
ketonic fraction of impure "sodium pregnanediol 
0 o 
glucuroni date ". m. p.: - 147 - 149 (corr.) 




Tube. 8pekker.1 14ig. Recovd. 
as pregnane- 
diol. 































CONCLUSION: Although precipitation in the range of 
temperature 75° to 37° did not appear to be complete 
none the less relatively large amounts of this substance 
appeared in the final product after purification, and 
the fact that only traces of apparent pregnanediol were 
recovered when large amounts of pregnanolone were 
added, is due to the very low chromogenicity of this 
steroid. Pregnanediol is approximately 40 times 
more chromogenic in the sulphuric acid reaction. 
A gravimetric method of determination 
would therefore yield fictitiously high results. 
Whereas androsterone and isoandrosterone 
precipitated out as large plaques, the precipitate 
formed by pregnanolone was a fine dispersion and 
considerable loss occurred in the syphoning off of the 
supernatant solution. 
(5) Allopregnanolone: allo- pregnan- 3(c()° -o1 -20 -one 
34. 
standard solution of the pure compound, 
m. p. 191°- 195 (corr. ) 




pekker. Mg. Recovd.as 
pregnanediol. 




0.5 0.002 0.005 1.0 0.25 50 
0. 5 0.005 0.007 1.4 0.40 80 
1.0 0.010 0.012 1.2 0.77 77 
1.0 0.012 0.015 1.5 0.95 95 
2.0 0.017 0.020 1.0 1.40 70 
2.0 0.020 0.022 1.1 1.60 80 
4.0 0.045 0.055 1.4 3.72 93 
4.0 0.032 0.040 1.0 2.65 66 
CONCLUSION: As in the case of pregnan- 3(a) -o1 -20 -one 
the very low recovery of apparent pregnanediol depende 
almost entirely upon the low chromogenicity of this 
steroid. Recovery of the allopregnanolone was actually 
higher than the recovery of pregnanolone but the former 
substance is even less chromogenic than the latter - 
possessing approx. one -eightieth of the chromogenicity 
of pregnanediol. 
(6) Àl1opr@gnanediof: álloçregnane 
Although it has not yet been proved that this 
.compound occurs as a glucuronide in pregnancy urine, 
it has been isolated from that source and as it might , e 
expected to behave as its stereo- isomer its behaviour 
in the purification process was of particular interest 
Standard solution: 10.078 mg. in 50 ml. ethanol. 



























































































Spekker. Mg Recovd 
as preg- 
nanediol. 












0.018 0.020 20 0.027 
0.012 0.014 14 0.020 
0.105 0.125 63 0.162 





0.182 0.215 72 0.280 93 
0.179 0.212 71 0.277 92 
0.252 0.298 75 0.388 97 
0.247 0.292 73 0.380 95 

























CONCLUSION: Alloloregnane- 3(cX),20,o6.diol behaves 
like pregnane -3(6),20 -diol in pure solution. The 
aÿparent recovery of pregnanediol is 20 less, however, 
due to the fact that allopregnanediol is less chromo- 
:genic to this degree. As this observation on the 
chromogenicity had not been made previously, the 
experiment was repeated with fresh standard solutions 
and, after checking the purity of the allo-pregnane-3 
(d), 20oí diol, almost identical calibration curves 
were obtained. It may be concluded therefore that 
the method determines a mixture of the two stereoisom- 
:ers of oregnane- 3(d.),2046,- diol. 
37. 
In other experiments on specificity it seems 
likely that by using pure solutions of the steroids, 
as described, the conditions would rather favour inter- 
ference and be a severe test of the specificity of the 
method. In this case, however, where a quantitative 
recovery is obtained in pure solution it will be 
necessary to repeat the experiment in the presence of 
N.F. M. U. It might be that greater or less loss would 
occur during purification in the presence of R. ±. i4?. U. 
than is the case with pregnane- 3(d.), 2040(r diol. This 
will be done as soon as sufficient allopregnanediol has 
been prepared 
2 
or ( 7 ) 0 A..TTDROSTENE-17-0NE. 
Standard solution: 20.155 mg. in 20 ml. ethanol¡. 
A2 or 3 
IAndrostene.e 
Spekker. 
17 -One added 
(mg.) 
Ptilg. Recovd. 'lig. Rcóvd. 











































CONCLUSION: The apparent pregnanediol recovery 
obtained when this compound was subjected to the triple 
precipitation process was satisfactorarily 
low. This 
38. 
result was, however, to some extent due to the fact 
that this 17-keto steroid has approx. one -twentieth 
of the chromogenic _cower of pregnanediol in the 
sulphuric acid reaction. 
(8) A3'S ANDROSTADIENE - 17 - ONE. 




Spekker. Mg Recovd. 
as pregnane- 
dio1. 

















0.027 2.7 0.037 3.7 
0.045 4.5 0.057 3.7 
0.082 4.1 0.150 7.5 
0.055 2.8 0.095 4.8 
0.53 13.1 0.95 23.8 
0.70 17.5 1.28 
3.75 46.9 6.75 84.4 
2.30 28.8 4.18 52.3 
CONCLTrsTnN: Elimination is fairly adequate when this 
steroid is present in amounts corresponding to less 
than 10 mg. /24 hr. Apparent pregnanediol recoveries 
of ca. 20;; were obtained in the presence of amounts 
corresponding to 20 -30 mg /24 hr. Data is not available 
concerning the possibility that amounts of this sub - 
:stance in excess of lOmg /24 hr might occur in patholo- 
gical urine, but it is unlikely that this rather rare 
steróid will interfere with determinations in urines 
other than those in which very large amounts of steroids 
of adrenal origin are present. 
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(9) CHOLESTEROL. 
Standard solution: 40.030 mg. in 20 ml. ethanol. 
Cholesterol 
added (mg.) 
















2. 0 0.012 0.01L1 _ 0.7 0.030 1.5 
2.0 0.006 0.008 0.4 0.015 
; 0.8 
4.0 0.080 0.095 2.4 0.202 5.1 
4.0 0.124 0.148 3.7 0.315 7.9 
8.0 l'8.135 0.80 10.0 2.22 27.8 
8.0 0.110 0.65 81 1.65 20.6 
COYCLUSION: Cholesterol precipitated out at 75 °,in th 
tubes containing 4.0 and 8.0 mg. in pure solution. 
Very poor sedimentation occurred and at the end of 
centrifugation the supernatant solution was cloudy 
and opalescent. The majority of the precipitate was 
lost in this way, and the apparent recovery as pregnan- 
:ediol was very low except when amounts corresponding 
to 40 mg. /24 hr were added. Such amounts would not be 
found in human urine but the observation indicates the 
difficulty which would be encountered in an attempt to 
determine the excretion of pregnanediol in human bile. 
Cholesterol gave an.orange colour with sulphuric acid 
and had about one -third of the chromogenicity of 
pregnanediol under the conditions of colorimetry 
employed. 
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SUMMARY of SECTION II. 
The methods of urinary pregnanediol determin- 
:ations which have hitherto been described are either 
insuffici (tntly sensitive or insufficiently specific to 
permit of strictly quantitative studies upon the 
excretion of urinary pregnanediol during the menstrual 
cycle, the first trimester of pregnancy or upon that 
excretion of pregnanediol which results from the 
administration of progesterone to the human subject. 
The method described should make such studies more 
nearly possible. Most of the attributes of a suitabld 
method as envisaged in the Introduction have been 
attained. The method is simple and determinations can 
be carried out daily and in duplicate upon one -fifth 
of a 24 hr. urine specimen. Although two eight -hour 
working days are necessary for t lE completion of a 
single determination, the technique entailed on the 
second day's work is such that at least six detenmina- 
:tions can be carried through daily by one person. 
The method permits of the accurate determina- 
tion of more than ca.0.4 mg. of pregnanediol in one- 
fifth of a 24 hr. specimen. 
Several steroids which might be present in 
normal or pathological urines have been investigated 
as to their behaviour in the purification process. 
With the exception of the C5 stereoisomer of pregnane- 
:diol itself none of these compounds is likely to cause 
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serious interference unless present in very large 
amounts. The relatively specific nature of the methodr 
depends upon a providdntial state of affairs whereby 
substances of high chromogenicity are eliminatéd, and 
substances which are not completely eliminated are 
weakly chromogenic. Substances of the latter group - 
especially pregnan - 3(0.0.01-20-one and allopregnan- 
3 (o.)o1 -one which occur in pregnancy urine as glucuron- 
:ides will give fictitiously high results when present 
in urine where pregnanediol is being determined as its 
glucuronide or by a gravimetric method. 
SECTION /11. 
SECTION III. 42. 
A RAPID METHOD for the DETERMINATION of 
URINARY PREGNA?` EDI OL SUITABLE for 
ROUTINE CLINICAL USE. 
Introduction. 
The Guterman (1944, 1945) qualitative test for 
urinary pregnanediol, which is based on the quantit- 
:ative procedure developed by Astwood and Jones (1941) 
and Talbot, Berman, MacLachlan and Wolf (1941), has been 
widely used in recent years for the early diagnosis of 
pregnancy and for the prediction of the fate of 
threatened abortion. While there is some measure of 
agreement that the method may be useful for the latter 
purpose (Guterman, 1946; Bender, 1947,1948; Merivale, 
1948), opinions on its value for the diagnosis of 
pregnancy are sharply divided. Guterman himself (1944, 
1945) and McCormack (1946) have claimed an accuracy as 
great as that of the Friedman method; on the other 
hand, Reinhart and Barnes (1946) and Merivale (1948) 
have reported high percentages of both false positives 
and false negatives. 
It seems probable that the unsatisfactory results 
obtained by the last mentioned authors can be ascribed, 
to some extent, to technical deficiencies of the 
method employed - some of which are avoidable. 
A general criticism that can be justifiably made 
of the Guterman method is that a quantitative signifi- 
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: cance has been attached to the results of a purely 
qualitative test. Attempts have been made by a number 
of workers to make the test more quantitative by 
examining the colour spectrophotometrically instead 
of visually. (Davis and Fugo, 1947; Bender, 1947, 
1948; Kullander, 1948; Merivale, 1948; Guterman, 
1948). 
Mack and arks (1943, 1947) have described a 
qualitative test based upon the Astwood- Talbot and 
Guterman procedures, but purification of the precipitate 
and estimation of the final product are omitted and a 
result arrived at by the mere inspection of the 
precipitate. These workers state that "in samples 
containing 0.75 mg. or more of pregnanediol, a precipi- 
:tate is evident immediately ". If no precipitate is 
visible the precipitation mixture (acetone is used) is 
cooled rapidly in an ice -water bath for ten minutes, 
removed from the bath and observed once more. "Roughly 
quantitative estimates of the precipitate" are obtained' 
by centrifugation of the precipitate in a graduated 
tube and the results are expressed by these workers in 
ml. pregnanediol per specimen. 
since, as has been shown in the previous section, 
there are inherent in these methods, a considerable 
number of factors conducive to inaccuracy, it seemed 
possible that by replacing these by more favourable 
conditions a reasonably quantitative method might be 
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evolved which would be no less rapid and simple than 
such unsatisfactory procedures. 
An attempt was therefore made greatly to reduce 
the time taken for a single determination by modifica- 
:tion of the method described in Section II. This 
could only be achieved at the expense of the accuracy 
and specificity of the method. It was hoped that a 
reasonable degree of accuracy could be maintained by 
retaining essential features of the original procedure. 
A high degree of specificity in the presence of 
abnormal amounts of such substances as cholesterol andl 
the neural 17- ketosteroids would not be demanded of a 
method employed in the routine determination of urinary 
.pregnanediol excretion in pregnancy. The destruction 
of pregnanetriol by acid hydrolysis and the very low 
chromogenicity of pregnanolone and allopregnanolone 
would make interference by these substances unlikely. 
(1) Male Urine Blanks: The most effective way in which, 
reduction in time from two days to a few hours could be 
achieved was by elimination of the 2nd and 3rd pptns. 
The most serious consideration involved in such a step 
was the effect upon the elimination of the chromogenic 
material of the N.F.M.U. It seemed possible that by 
slow cooling of the precipitation mixture followed by 
filtration of the large "crystals" through a filter 
of such a porosity as to permit adequate elimination 
of these chromogens with retention of the precipitated) 
pregnanediol, that high "blank" values would be avoided. 
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A sintered glass filter of ay. por. diameter 294.- 
30Aproved satisfactory for this purpose. In addition 
treatment of the final product with charcoal was 
carried out as in the original method. 
Blank determinations were carried out in triplicate 
on eight 100 ml. samples from 24 hr. urine specimens 
collected from seven different normal men, and the 
apparent pregnanediol determined by the shortened 
procedure. The results are shown in Table 13. 
CONCLUSION: The values for apparent pregnanediol 
excreted per 24 hours varied from 0.13 to 0.61 mg. 
The highest of these values is so much smaller than 
the lowest amount of pregnanediol which could be deter - 
:mined by the proposed method that error due to this 
cause would be negligible. 
(2) Rapid method adopted after modification of the 
Original method. 
The procedure was worked out bearing ±n mind the 
results of the recovery experiments which led up to 
the adoption of the original method. For example, 
the possibility of omitting overnight incubation of the 
precipitation mixture was suggested by the results 
shown in Table 9. Little loss was anticipated by 
the omission of the second and third extractions of 
the hydrolysed urine with consequent reduction in the 
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Into a 500 ml. flask fitted with an interchangeablie 
ground -glass joint and a reflux condenser is placed 
100 ml. of a 24 hour urine specimen, the volume of 
which is measured, and 50 ml. of toluene ('sulphur- 
free', redistilled). The contents are heated to 
boiling and after the addition of 10 ml. concentrated 
Hal (A.R. quality) the boiling is continued for exactly 
10 minutes. The mixture is cooled, transferred to a 
250 ml. separating funnel and shaken. After standing 
for about 5 minutes the lower urine layer is run off 
and discarded, and the upper toluene- emulsion layer 
filtered through a Buchner funnel with gentle suction 
using a Whatman No. 1 paper in order to break the 
emulsion. The filtrate is then transferred back into 
the separating funnel and the lower urine layer that 
separates from the emulsion is run off and discarded. 
The toluene layer is washed in the funnel twice 
with 15 ml. lots of N/1 NaOH and twice with 15 ml. lots 
of water. It is then transferred to a 200 ml. round - 
bottomed flask fitted with a bent ground -glass 'socket 
ada3ter' (Quickfit and Quartz) and evaporated to dryness 
under reduced pressure in a boiling water -bath. 
The residue in the flask is quantitatively 
transferred with warm ethanol to a test -tube (1" diam) 
which has a graduation mark at the 5 ml. level. The 
solution is then evaporated to 5 ml. in a warm water - 
bath under a gentle stream of air. After placing the 
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tube in a beaker of water at 75 °C, 20.ml. of N /10 NaOH 
are added slowly from a burette over a_ period of 3 
minutes while stirring gently with a glass rod. After 
a further one minute the beaker and tube are transferred 
to an incubator at 37 °C and left for 2 hours. 
The contents of the tube are then filtered through 
a sintered glass funnel (3 cm. diam. plate; average 
por. diam. 20 -30 microns), the tube and filter being 
subsequently washed liberally with water to remove all 
traces of alkali from the precipitate. The funnel is 
removed from the filter flask and fitted to a test -tube 
(1" diam.) fitted with a side -arm. The precipitate 
is then washed through into the tube with three 5 ml. 
lots of boiling alcohol using gentle suction. 
To the filtrate in the filter -tube is added about 
1 - 2 mg. of 'Norit' charcoal, the mixture heated in a 
water -bath for 2 minutes, and filtered through á 
Whatman No. 1 gaper in a conical filter (2" diam.) into 
a test -tube (1" diam.). The filtrate is finally 
evaporated to dryness in a water-bath under a stream 
of air. 
To the dry residue in the tube are added 10 ml. of 
concentrated H2SO4 (A. R. quality) . The tube is placed 
in a constant temperature bath at 25° and left for 20 
minutes with occasional shaking. The intensity of th 
yellow colour produced is then measured in a 'Spekker' 
photoelectric absorpü.ometer using a 'spectrum violet' 
No. 601 light filter. The absorptiometer readings 
TABLE 14. 
Recovery of pregnane -3(0),20o& di of added to men'S 
urine after acid hydrolysis. 
Mg. pregnane- 
diol added. 
Mg. pregnanediol recovered 
(corrected for average male 
urine blank). 
Urine per 100 
ml. 
urine. 
per 24 -1,er 100 ml. 
hrs 
urine. 
per 24 hrs 
urine. recovery. 




- - 0.02 0.02 0.25 0.23 - - 0.02) 0.28) 
B - - 0.02 0.27 
- - 0.03 0.02 0.54 0.40 
- - 0.02 0.40 
A 0.20 2.8 0.10 1.3 48 
0.05 0.71 26 
tt tt 0.06 0.88 32 
B t' 3.6 0.17 3.1 87 
t' t' 0.11 1.9 53 
tt 
t' 0.19 3.4 94 
B 0.30 5.4 0.31 5.5 102 
tt It 0.25 4.5 83 
It ft 0.28 5.2 94 
A 0.40 5.6 0.28 3.9 70 
It tt 0.24 3.3 60 
0.34 4.7 85 
B 0.40 7.2 0.35 6.3 88 
It ft 0.34 6.1 85 






















9 It 0.45 8.1 90 
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are interpreted by reference to frequently reconstructed 
calibration curves as in the original method. 
(3) Two 24 hour urine specimens (A. and B.) were 
collected on successive days from the sane normal male. 
(I.F.ä.) Twelve 100 ml. samples were taken from 
specimen A and fifteen from B. After hydrolysis of 
these with HC1, amounts of pure pregnane- 3(00,200diol 
varying from 0.2 to 0.6 mg. were added in ethanolic 
solution, three samples from each specimen being 
reserved as triplicate blanks. The ,pregnanediol 
in each sample was then determined by the method 
described and the recoveries calculated after correcting 
for the appropriate blank. 
The results are given in Table 14. 
CONCLUSION: The method developed permits of the 
reasonably accurate quantitative determination in less 
than 3 hours of the pregnanediol in 100 ml. of urine, 
provided that the level of excretion is above about 5 
mg. per 24 hours. The method is advocated for the 
routine determination of pregnanediol excretion in 
pregnantly but not for quantitative studies in non - 
pregnant urine, or in urine containing abnormally high 
amounts of neutral 17- ketosteroids or in the study of 
the excretion of administered progesterone as 
pregnanediol. For all such studies, where higher 
degrees of accuracy and specificity are required the 
longer method should be employed. This rapid method 
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has been used for several months in the Department of 
Obstetrics and Gynaecology (Edinburgh University) for 
a study of the possible value of pregnanediol determina- 
:tions in the assessment of prognosis in threatened 
abortion. Satisfactory duplicate results are being 
obtained but it is as yet too early to draw any conclu- 
:sions from this work. All the determinations reported 
in this thesis were carried out by the longer but more 




THE CONVERSION of PROGESTERONE to URINARY 
P'REGNANEDIOL by the HUMAN SUBJECT. 
Introduction. 
Since the suggestion by Yenning and Browne (1938 ) 
that some sort of quantitative relationship might exist 
between progesterone _;roduction in the body and. pregnade- 
:diol excretion in the urine, several workers have 
sttdied the excretion of urinary pregnanediol after they 
administration of progesterone to human subjects. 
These studies will be considered in some detail but it 
may be said at the outset that they indicate a marked 
variation in the extent of conversion among different 
individuals and in the same individual at different 
times. The amount of pregnanediol glucuronide 
appearing in the urine in such investigations appears 
to be of the order of l0;-ó of the administered 
progersterone but published data vary from 0 to 50. ". 
Two facts suggest the possibility that this 
apparent variation may not be a true statement of the 
extent of conversion in the normal individual. In 
the first place, as has been indicated in Section II, 
methods hitherto employed have not permitted the 
satisfactory quantitative determination of less than 
ca. 10 mg. /24 hr and these methods have been applied 
to material in which this level has rarely been 
attained. (If i,he j conversion is ca. 10s then 100 
mg. would have to be administered daily to produce 
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this level of urinary pregnanediol). Secondly, for a 
proper assessment of this conversion under physiological 
conditions it is obviously desirable that a series of 
normal subjects should be investigated, and such 
studies are not to be found in the literature., 
These facts and the completion of the work on the 
improved method for the determination of urinary 
pregnanediol suggested a reinvestigation of the problem. 
The subjects chosen for the f first jtase of the 
investigation were either healthy young men or healthy 
post- menopausal women. The procedure was as follows: - 
A control period was followed by the administration of 
60 mg. of progesterone (Organon; 10 mg. per ml.) on two 
successive days either by intra- muscular injection or 
by capsules orally. The urinary pregnanediol was 
determined during the control period and for six to 
eight days after the first administration, by which 
time the excretion of apparent pregnanediol had 
returned to the "blank" value. The determinations 
were carried out daily and in duplicate by the original 
method (Somerville, Gough and Marrian, 1948) on aliquot 
portions of 24 hour urine specimens and the ó cònversion 
calculated after correction of the apparent pregnanediol 
excretion for the control period blank. 
All twenty -four hour specimens of urine of volume 
less than 2500 c.c. were diluted with distilled water 
to that volume and two lots of 500 c.c. used for the 
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duplicate determinations. where the urine volume was 
more than 2500 c. c. , 500 c.c. lots were taken and the 
result corrected for the additional volume. 
Ovariectomised women were the obvious choice for 
investigation of the conversion of administered progeu- 
:terone to urinary pregnanediol with a view to obtaining 
a control series for the interpretation of sub seáuent 
studies. 
Healthy ovariectomised women were not available, 
however, at this time and there was no possibility of 
collecting a sufficient number of such cases on which 
to carry out the studies envisaged. Moreover, bearing 
in mind the indications for this operation, it seemed 
unlikely that the terms "healthy" or "normal" could 
properly be ascribed to the majority of ovariectomised 
women. 
On the other hand it was - ossible to select a 
sufficient number of apparently healthy women from 
among those who had experienced the physiological 
withdrawal of ovarian activity at the menopause. As 
volunteer post- menopausal women were not forthcoming, 
women were chosen in whom there was a mild or moderate 
degree of prolapse of the uterus. 
The investigation was carried out in each patient' 
home and care was taken to select subjects whose 
temperament and home conditions made it seem likely tha 




of urine. The cases agreed to stay in or around 
their homes during the investigation. collection of 
urine under these conditions was found to be more 
reliable than collection by the nursing staff in the 
busy wards of the gynaecological unit. It was 
necessary to check the completeness of 24 hr specimens 
collected in hospital by daily determination of the 
urinary creatinine by the method of Folin (1914). The 
use of this method for this purpose was reviewed by 
0.W. Smith in 1942. 
(1) ADMINISTRATION OF PROGESTERONE TO HEALTHY POST- 
MENOPAUSAL WOMEN. 
Determination -of pregnanediol in the urine after 
the administration of progesterone to a series sof 
healthy post -menopausal women has not been reported 
but investigations in women in whom there was reason 
to believe that endogenous progesterone production 
was absent or very low, were first described by 
yenning and Browne (1938). Thus 12' ov the adminis- 
tered dose was recovered from the urine as pregnane- 
;diol glucuronide from a young ovariectomised woman. 
Cope (1941) found a 6 recovery in a case of 
hypoplasia of the uterus and 9A in a case of anovulat- 
:ory menstruation. 
Seegar Jones and TeLinde (1941) report a recovery 
of 10; in the pre -ovulatory phase of the menstrual 
cycle. 
Hamblen, Ashley and Baptist (1939) and Stover 
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and Pratt (1939) were unable to detect pregnanediol in 
the urine after progesterone administration. 
For the present purpose, three post- menopausal 
women aged 65, 70 and 71 were chosen. All three were 
in excellent health and had normal menstrual and 
obstetric histories. The results are given in table 
15. 
Subject. Age. Progesterone Pregnanediol 
administered recovered 
(mg.) (mg. corr.) 
ï0 Recovery. 
M. E. 65 120 18.73 15.61 
A. 70 120 18.67 15.56 
J. N. 71 120 19.17 15.98. 
Av. . 15.72. 
CONCLUSION: The finding of such closely similar 
patterns of excretion of pregnanediol and yo conversion 
in three random cases suggested the presence of some 
very definite metabolic process which could be studied 
in terms of this metabolite - pregnanediol - by this 
type of experiment. Pregnanediol disappeared from 
the urine within three to four days of the second 
injection of progesterone. 
(ii) HEALTHY YOUNG MEN. 
The excretion of urinary pregnanediol after the. 
administration of progesterone to males was first 
reported by Buxton and Westphal (1939) . 17,E of 
injected progesterone was recovered from the urine of 
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a normal male as pregnanediol and much larger amounts 
(67;Ï on one day) from a case of Addison's disease. 
Hamblen, Cuyler and Hirst (1940) reported a variation 
in the _degree of conversion of from 0 to 42.5 with 
markedly differing extent of conversion in one male on 
different occasions: this case was given 120 mg., 
120 mg., 80 mg. and 40 mg. of progesterone and couver- 
: sion to 25 %, 39; , 4 and 7% respectively resulted. 
Dorfman, Ross and Shipley (1948) report the 
results of administration of progesterone by mouth 
(progesterone as dispensed for intra- muscular 
administration given orally by capsules) to one male 
with Addison's disease and to one with Diabetes 
Mellitus. In the former, conversion to 3 and 7: of 
the administered dose occurred and, in the latter, to 
18.3, 8% and 19.5.ïß. These results and the others 
mentioned above were determined by the method of 
Yenning. Dorfman et al. (1948) confirmed the-work of 
Marrian and Gough (1946) and established preg- 3(d) -ol- 
20 -one as a metabOlic product of progesterone by 
isolating this 20- ketosteroid from the final product. 
They concluded that 10, of the final product was 
pregnan -3(oß) -o1 -20 -one. 
The present investigation was carried out on 
three normal male volunteers aged 22 to 23 years. 
The procedure was carried out on four occasions on 




















































































NORMAL POST -MENOPAUAL NOMEN. 
subject.: E. A. N. 
















- 1290 0.20 2310 0.07 - - 
0.15 0.06 
- 2000 0.11 2420 0.04 1400 0.16 
0.10 0.06 0.24 
Prog. 1270 0.26 2125 0.08 1380 0.21 
60 mg. 0.23 0.05 0.23 
I.M. 
" 1470 4.52 2305 2.38 1800 4.80 
4.62 2.45 5.03 
- 1600 7.05 2720 6.88 1460 7.75 
6.75 6.75 7.90 
- 1250 4.22 2380 4.55 1395 4.95 
4.25 4.25 5.05 
- 910 2.63 2370 2.98 940 2.18 
2.68 3.00 2.13 
- 1260 1.16 2240 1.81 1200 0.28 
1.10 1.88 0.33 
- 970 0.28 2605 0.74 1615 0.26 





19.63 19.13 20.22 
1 
" " corr. 
for "blank mg.18.73 18.67 19.17 
% recovery. 15.61 15.56 15.98 
TABLE 16. 
NORMAL MEN - PROGESTERONE I.M. 
Subject: D.P. J.P. A.R. 














- 1340 0.23 1300 0.14 1800 0.33 
0.20 
: 0.19 0.28 
Prog. 1030 0.26 1090 0.34 2000 0.20 
60 mg. 0.34 0.25 0.24 
I.M. 
" " 1400 2.85 1400 3.50 2570 3.55 
2.94 3.70 ' 3.70 
- 2410 5.80 1305 8.80 ; 3660 4.47 
5.45 9.05 4.57 
- 1500 2.80 1265 4.00 1850 2.23 
2.73 3.75 2.15 
- 1350 2.18 1180 1.33 1980 1.31 
2.23 1.43 1.28 
- 1430 0.31 1315 1.03 2175 0.59 
0.24 0.93 0.68 
- 1330 0.26 1060 0.36 1600 0.18 
0.25 0.30 0.24 
- 1800 0.16 - - 2580 0.24 
0.24 0.20 




12.47 17.65 11.13 
"blank". 
;3 Recovery. 10.39 14.71 9.28 
TABLE 16a. 
Pregnanediol recovered from urine of normal men after 
the administration of progesterone (2 x 60 mg.) 




% recovery of 
pregnanediol 


















J. P. 23 17.12. 47 
17. 4. 48 
22.4.48 
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( ) 12.57 12.02 10.01 
(b) 13.54 12.99 10.82 
( ) 12.49 11.94 9.97 
FIGURE 2. 
















REPEATED PROGESTERONE ORAL ADMINISTRATION 
MALE: . . 
Admin. Vol. Preg. 
c. c. mg./24 hr. 
Admin. Vol. Preg. 








































































(a) 23.56 22.31 18.59 
(b) 22.09 20.84 17.37 




: ORAL ADMINISTRATION. 
Subject A.R. D.P. 
Date: 
12.8.48 10.5.48 
Admin. Vol. Pregnanediol Vol. Pregnanediol 
c.c. mg. /24 hr. c.c. mg. /24 hr. 
- 3300 0.19 - - 
0.13 
Prog.60 2020 0.11 1840 0.33 
mg.Oral 0.11 0,26 
Prog.60 1940 2.14 1500 7.30 
mg.Oral 2.10 7.20 
- 2685 11.50 1160 8.15 
10.60 8.25 
- 2395 0.25 1190 0.56 
0.28 0.63 
- 1860 0.13 1400 0.54 
0.12 0.38 
- - - 1060 0.36 
0.30 
- - - 1615 0.25 
0.29 
App. preg. 
recov. mg. 14.26 16.83 
" " corr. 
for "blank" mg. 13.84 15.33 
, Recovery 11.53 12.75 
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a remarkable degree of reproducibility are given in 
Table 16(a). 
Oral administration of progesterone in capsules 
resulted in more rapid absorption and excretion at" 
progesterone as pregnanediol and a slightly higher 
rate of conversion. Oral administration was repeated 
on three occasions in Subject J.P. (Table 17) and 
again a high degree of reproducibility was obtained. 
There is a quite convincing parallelism between the 
conversion by either route in the three individuals. 
Although two subjects gave a conversion ca. 5; lower 
than that found in post- menopausal females, the extent 
of conversion by the third was similar to that of the 
females. The slightly higher rate of conversion which 
followed gastric administration was a constant feature 
and is consistent with the view - which will be 
discussed later - that the liver plays an important 
part in the metabolism of progesterone. 
(iii) The Effect of Oestrogen Administration on the 
Conversion or Administered Progesterone to 
Urinary Pregnanediol. 
Yenning and Browne (1940) studied the excretion of 
pregnanediol glucuronide after progesterone adm_inistra- 
;tion in two cases of secondary amenorrhoea with 
hypoplastic endometria. small doses of progesterone 
were given i.e., 8 mg. daily for three days; and 10 
mg. daily for eleven days. The percentage of admin- 
istered progesterone excreted as urinary pregnanediol 
57. 
in these cases was 0. and 1.7. After pretreatment 
with Oestradiol Banzoate of the order of 10,000 I.U. 
for six to twelve days the recovery of pregnanediol 
rose to 18 ;; in the first case and to 17gó in the second 
case. These workers concluded that the excretion of 
pregnanediol was facilitated by the building up of the 
endome t rium with oestrogens. 
Cope (1939) using a similar dose of progesterone - 
10 mg. daily for five days, determined the urinary 
pregnanediol in a similar case - secondary amenorrhoea 
with hypoplasia uteri - using a slightly modified 
version of the Yenning method. The result was the 
direct opposite of that reported by Yenning and Browne. 
Before Oestrogen pretreatment, 6ï of the administered 
dose was recovered as pregnanediol in the urine but 
after administration of 20,000 I.U. of Oestradiol 
Benzoate daily for three weeks, only 3 was recovered. 
Smith and Smith compared the effect of progester 
One alone and of progesterone _plus oestradiol benzoate 
upon the excretion of pregnanediol in pregnancy and 
suggested that oestrogen favoured the conversion of 
progesterone to pregnanediol. These workers stress 
the importance of this observation and it forms one of 
the fundamental "facts" in a wide- reaching hypothesis; 
yet the experimental evidence is not entirely convincin 
Endogenous progesterone production complicates inter- 













































































































In the present work, three healthy postmenopausal 
women of the type used in series (i) were selected. 
Progesterone (60 mg. intra- musc.) was administered 
on two consecutive days after six daily injections of 
30 mg. Oestradiol Benzoate to two of the subjects. 
In the third, two injections of 120 mg. progesterone 
were administered after twenty daily injections of 
oestradiol benzoate. The daily injections of 
Oestradiol Benzoate were continued for the two days of 
progesterone administration and for two subsequent 
days. 
The results are given in Table 19 and compared 
with those obtained from the untreated postmenopausal 
women in Table 19(a). 
In subjects H. and B., total hysterectomy and in 
subject K. endometrial biopsy were performed five to 
seven days after the last injection of Oc:stradiol 
Benzoate. Por the interpretation of the microscopic 
sections of these endometria we are indebted to Dr 
W.I.C. Morris, F. R. C. S. , F. R. C. 0. G. 
Effect on Endometrium: 
(a) Subject H. : A microphotograph of the uterine 
. 
scrapings is shown opposite. The appearance is that 
of a typical simple atrophic endometrium. There was 1 
a simple erosion of the cervix with a mild inflammatory 
reaction. 
SUBJECT "H" 
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recov. mg. 20.08 19.81 38.31 




19.60 19.36 36.21 




(b) Subject B. : The microphotograh shows a conditio 
of the endometrium markedly different from that in the 
previous case. There is a thick active endometrium in 
which the majority of glands show proliferative 
activity. "In a few spaces secretory changes are 
manifest i.e., single layer of cells, sagellate outline 
displacement of nuclei towards the basement membrane;, 
globules of secretion in the superficial parts of the 
cell, and cytoplasm crumbling down into the gland 
lumen., Even in such secretory glands, mitotic figure 
are occasionally seen. The stroma is in general 
that of the proliferative phase, numerous closely 
packed cells with densely staining nuclei and scanty 
cytoplasm. The cervix shows hyperkeratosis but not 
of more than would be expected in a case z prolapse. 
No sign of activity in cervical glands, no vigorous 
proliferation in squamous epithelium. The vaginal 
skin shows definite hyperkeratosis more than might 
have been anticipated in such a case not receiving 
oestrogentherapy. No evidence of unusual mitodes 
in the deeper layers of vaginal epithelium." 
(c) :subject K. : The t.ndometrium in this subject 
also shows features of the proliferative phase and the 
pathologist reported as follows: "A proliferative 
phase endometrium, largely necrotic with some evidence 
of inflammation signified by the presence of plasma 
cells infiltration. Glands are cylindrical with 





Many cells show vacuoles, some subnuclear but the 
majority supranuclear. The stroma is cellular with 
spherical and polygonal cells but no mitoses." 
CONCLUION: As shown above, the recovery of 
pregnanediol from the urine expressed as a ö of the 
dose of progesterone administered was almost identical 
to that found in the untreated post -menopausal women. 
This occurred despite the administration of 240 mg. of 
oestradiol benzoate over a period of eight days to 
subjects H. and B. and 600 mg. of oestradiol benzoate 
over a period of twenty days to subject K. and despite 
the differing effects which this and the progesterone 
therapy appeared to produce in the endometria of the 
postmenopausal uteri. The results are strongly 
suggestive of the view that the oestrogen pretreatment 
of the postmenopausal subject in general and uterine 
endometrium in particular does not influence the 
conversion of administered progesterone to urinary 
pregnanediol. This will be further investigated. It 
might be argued that a threshold dose of oestrogen 
had been administered to subjects H. and B. which woul 
not be high enough to ensure an effect on the endomet- 
:rium in all cases. It seems more likely however th 
this short series illustrates the variation in respons 
which occurs between individuals who are subjected to 
the same hormonal therapy and how unwise it would be t 
assume that because therapy has been dispensed the 
t 
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the desired biological effect will be attained. The 
possibility that oestrogen administration might influ- 
: ence progesterone metabolism under different experimen- 
tal conditions was considered and it is believed that 
in preliminary work described later in this section 
conditions obtain which more closely resemble some 
aspects of the interrelationship of those two hormones 
during active, reproductive life. 
(iv) Conversion of Progesterone to Pregnanediol by 
HYSTERECTOMISED POSTMENOPAUSAL WOMEN. 
In 1938, yenning and Browne reported that 
pregnanediol glucuronide could not be recovered from 
the urine after the administration of progesterone to 
two hysterectomised women - even after the injection 
in one case of 24 mg. progesterone daily for four days. 
In a third case (1940) in whom supravaginal hysterec- 
:tomy had been performed 9.62., of the injected progester- 
:one (30 mg. daily for three days) was recovered. 
Hamblen.(1939) reported that pregnanediol, normally 
present during the luteal phase of the menstrual cycle, 
did not appear in the urine following; curettage of the 
uterus. 
Buxton, 1940, administered Progesterone by intra- 
muscular injection to four hysterectomised women, in 
the form of 30 mg. daily for three days. In two cases 
no pregnanediol glucuronide was detected in the urine 
but in the third and fourth cases, 3.7 mg. and 4.9 mg. 
62. 
were determined constituting 4;0 and 5; of the adminis- 
tered dose respectively. 
Seegar Jones and TeLinde (1941) reported recovery 
of 15.6;-, from a panhysterectomised woman and 12.9; and 
l0.9:ó from two women after supravaginal hysterectomy 
in whom 40 mg. of progesterone were injected on three 
successive days. Of great interest was the determina- 
tion of 6.1 mg. of pregnanediol glucuronide on the 
16th and 17th days of a menstrual cycle in a woman 
who had a total hysterectomy on the first day of that 
cycle. 
In the present work, :progesterone administration 
and the determination of urinary pregnanediol were 
carried out as in the previous series. Subject H. 
(series iii) was investigated five weeks after vaginal 
(total) hysterectomy had been performed. Subject L. 
(aged 42) who was not menopausal had been hysterectomised 
three weeks previously because of large uterine 
fibro -myomata. Subject R. was also suffering from 
uterine fibro -myomata and was investigated two weeks 
and again twenty -four Weeks after vaginal hysterectomy 
and bilateral ovariectomy. Subject M. was a post- 
menopausal woman in whom vaginal hysterectomy was 
carried out prior to pelvic floor repair in the treat- 
ment of prolapse of the uterus. Subject M. was 
investigated two weeks and again 20 weeks after 
hysterectomy. 
63. 
The results and certain data relating to these women 
are given in Table 20. 
CONCLUSION: The possibility that irregular results 
might be found in this series was anticipated since it 
was obviously impossible to investigate a normal 
postmenopausal woman who had undergone hysterectomy. 
In addition some postoperative factors might influence 
the result and while these would be of considerable 
interest in themselves, they would obscure the point 
at issue which was to find out whether the hysterecto- 
:mised woman differed from the intact postmenopausal 
woman in her ability to convert admini_tered progester- 
one to urinary -regnanediol. 
Two cases investigated within two weeks of 
hysterectomy converted the administered )rogesterone 
to amounts of pregnanediol higher than had been 
previously observed in our subjects. Whatever the 
fundamental cause of this change it appears to have 
been related to the short period which had elapsed 
since the operation and when the investigations were 
repeated in the same woman 20 to 24 weeks later, 
figures very similar to those of the intact women were 
obtained. The trauma of the operation and the tissue 
repair which followed might alone have some bearing 
upon the problem and some speculation upon the 
relationship of the enzyme glucuronidase - the 
TABLE 20a. 
HYSTERECTOMIBED POST- MEI"OPAUSAL WOMEN. 
subject: M. M. 









850 0.20 1555 0.16 
0.22 0.20 
Pro g. 60 1040 0.13 1340 0.05 
mg. I.M. 0.14 0.08 
Prog. 60 1210 5.42 1670 3.45 
mg. I. M. 5.35 3.53 
1300 9.95 1280 7.20 
10.05 7.25 
980 4.82 1180 4.08 
4.88 4.28 
1160 2.61 1570 1.47 
2.68 1.46 
1025 1.40 1110 0.23 
1.43 0.16 
1400 0.51 1010 0.11 
0.46 0.10 
1580 0.19 - - 
0.08 
950 0.14 - - 
0.19 
App. preg. recovery.24.79 16.59 
» " corr. for 
"blank". 23.71 15.99 
; Recovery. 19.78 13.33 
TABLE 20b. 
HYSTERECTOMISED POST -MENOPAUSAL 'OMAN. 
subject: R. R. 
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"blank" mg A 
23.19 17.89 
























Prog. 60 870 0.15 2375 0.23 
mg. I.M. 0.14 0.19 
Prog. 60 1280 4.55 2700 2.44 
mg. I . íYi. 4.80 2.36 
970 8.00 840 3.85 
8.05 3.80 
1010 3.65 1650 3.48 
3.60 3.42 
1 60 1.16 1820 1.30 
1.17 1.20 
1140 0.34 1795 0.55 
0.28 0.66 
1320 0.13 1455 0.16 
0.18 0.18 
App. preg. recov. 17.82 11.81 
Corr. for "blank" 16.97 10.91 
Recovery. 14.14 9.09 
63a. 
concentration of which is raised in damaged and 
regenerating tissues - to progesterone metabolism are 
discussed in Section VIII. During the immediate 
,postoperative period. the women had been subjected to 
therapy by a variety of drugs over which we had no 
control. Apart from the anaesthetic, which was a' 
barbiturate (pentothal), sulphonamides, penicillin, 
and salicylates were administered to these two cases 
alone. During the investigation subject R. developed 
a Pulmonary Embolism and Heparin; was administered on 
the day following the injection of progesterone and 
for one week subsequently. As the high recovery in 
this case was due to an increased output of pregnanediol 
during the time of Heparin administration the possibil4 
:ity was considered that Heparin was the cause of this 
result. Since Heparin contains .Glucuronic acid the 
possibility that it might play some part in the little 
understood mechanism of conjugation of pregnanediol 
was considered. These speculations were discouraged, 
for the time being, by the very similar result obtained 
in subject M. who did not receive Heparin. The mattes 
cannot be dismissed, however, since as mentioned above 
/both patient S 
this case was receiving a host of medications /exhibited 
hyperpyrexia during the investigations due to pulmonar 
infection in subject R. and urinary infection in subject 
M. and it is not beyond the bounds of possibility that 
64. 
the associated toxaemia might be the factor responsible. 
If those subjects who were investigated in the 
immediate postoperative period are omitted from the 
present series then the following figures remain, and 
are comparable with those of the intact postmenopausal 
controls: 




If coincident administration of other drugs is 
the factor responsible for the high recoveries in R. 
and M. then the younger ;women, L. with a recovery of 
9.1 should be included in the series. 
In either case the conclusion is quite definite 
and it is that the postmenopausal uterus does not play 
an essential part in the conversion of administered 
progesterone to pregnanediol. It cannot be assumed 
however that the physiologically active uterus plays 
no part in the metabolism of progesterone and an 
attempt has been made to examine this wider problem. 
(vi) Conversion of Progesterone to Pregnanediol in 
cases of HYPERTEFoION. 
It was not intended to study a group of cases of 
this type but three cases of hypertension found their 
way into our investigations in the following manner: 
Subject S., aged 61, was a 'postmenopausal woman upon 
whom hysterectomy had been recently performed 
and 
65. 
hypertension was not noted until the investigation had 
begun. Blood pressure was of the order of 200/115 mm. 
Blood Urea was 40 mg. As the patient was in Edinburgh 
for only a few days after the interesting result of thee 
investigation had been obtained, it was not practicabl 
to repeat the investigation at a later date as in 
subjects R. and M. 
The other two cases were studied in connection 
with the possible effect of Heparin upon the conversion 
of progesterone to pregnanediol and it was not consider- 
ed justifiable to administer large doses of Heparin 
and the usual 120 mg. of progesterone to healthy 
subjects. The two cases available to us were as 
follows: - 
Subject A : A young man (age 49) with hypertension 
and severe bilateral Raynaud's disease affecting the 
hands. 
Subject H : An older man (age 47) with hypertension 
and intermittent claudication following traumatic 
arterial thrombosis. 
The results are given in Table 21. 
Subject. Age Blood Pressure 


























Subject: S. A. H. 
















1580 0.23 1370 0.15 1790 0.05 
0.21 0.08 0.04 
Prog. 60 1305 0.16 1400 0.10 1280 0.04 
mg. I. M. 0.22 0.06 0.06 
It It 1180 1.39 1620 0.66 1600 1.48 
1.34 0.73 1.40 
920 2.16 1580 2.62 1810 6.30 
2.13 2.68 6.50 
1220 1.43 1400 0.87 980 1.16 
1.46 0.78 1.11 
1380 1.18 1690 0.74 1580 0.19 
1.26 0.78 0.15 
1060 0.35 1620 0.65 1200 0.19 
0.29 0.56 0.10 
1020 0.15 1750 0.21 1400 0.07 
0.11 0.11 0.07 
App. preg. 
Recov. 6.48 5.86 9.37 
Corr. for 
"blank" 5.52 5.06 9.07 






















































































CONCLUSION: It seems unlikely that the low yield 
of pregnanediol in the two males studied was a result 
of the administration of Heparin in view of the high 
(19.37) yield in subject R. (series V) who received 
similar therapy. It cannot be concluded on results 
obtained in such unsatisfactory material that hyper - 
:tension or the underlying or associated phenomena 
which it signifies is responsible for a diminished 
capacity to convert administered progesterone to 
pregnanediol but the suggestion is there and further 
investigations are pending. Very careful assessment 
of the renal function in cases A and H was carried out 
in the Department of surgery and no impairment of 
renal function was detected. 
One conclusion which may be drawn from this group 
is the importance of selecting apparently healthy 
subjects wherever possible where an attempt is being 
made to elucidate a problem of physiology, although 
the fact that such variations occur suggests interest- 
ing possibilities for future studies in pathology. 
It was interesting to note that clinical 
improvement in the vascular insufficiently of the hands 
in case A appeared to follow the injections of proges- 
:terone. 
(v ) RECOVERY of PREGNAT_'EDIOL after administration of 
PREGNANEDIOL and of- SODIUM PREGNA. SDI e G UCURONI 
DATE. 
Yenning and Browne (1938) failed to recover 
pregnanediol glucuronide from the urine after intra- 
67. 
muscular injection of pregnanediol to two hysterectomied 
women. Injection of sodium pregnanediol glucuronidat 
(as prepared by Venning and containing ca. 20;i) sodium 
pregnanolone glucuronidate) resulted in the excretion 
of 58 ¡0. and 43; of pregnanediol in the same two cases. 
These were the cases which did not excrete pregnanediol 
after injection of Progesterone. The "Nape" was 
injected in aqueous solution - 20 mg. daily on three 
successive days. 
Hamblen, Cuyler and Hirst (1940) administered 
Sodium Pregnanediol glucuronidate (prepared by Venningts 
method) to six males by mouth. The recovery of the 
compound in the urine was extremely variable - 4;< to 
100 but the excretion in three of these subjects fell 
within the range of 30;,; to 50. 
In the present work the same three males as in 
series two were investigated. The procedure was 
identical to that observed on the previous occasion, but 
on the two consecutive days on which progesterone had 
been administered, pure pregnane -3(d,),20á -diol in olive 
oil was administered orally in capsules. The solution 
of pregnanediol in olive oil was prepared in the follow 
:ing manner: 140.3 mg. pure pregnane- 3(4),20d -diol was 
dissolved in 5 ml. ethanol and approximately 30 ml. 
olive oil added. The solution was heated until the 
pregnanediol was ®mpletely dissolved and the ethanol 
had boiled off. The olive oil was then cooled to room 
temperature and made up to the 50 ml. mark. 20 mi. of 
this solution contained 56.12 mg. of pregnanediol and 
TABLE 22. 
P RE GN AN E D I O L BY MOUTH. 
Subject: D. P. J. P. A. R. 
Date: 20.7.48. 29.7.48. 9.7.48. 
Admin: Vol. oregnane- Vol. pregnane- Vol. pregnane- 
c. c. diol mg./ c. c. hdiol 2g./ c. c. diol mg./ 
'24 hr. 24 hr. 24 hr. 
I 
1760 0.12 1665 0.25 1980 0.20 
0.13 0.24 0.21 
Preg.Oral 1560 0.11 960 0.29 3400 0.15 
0.19 0.26 0.26 
" " 1170 7.10 1160 9.30 1810 7.63 
6.95 9.33 7.53 
1265 5.80 1400 8.75 1960 5.18 
5.85 8.73 5.10 
1300 1.32 1600 2.29 2155 0.25 
1.31 2.15 0.23 
1820 0.08 1910 0.38 2365 0.21 
0.12 0.28 0.15 
App. preg. 
Recov. mg. 14.18 20.61 12.96 
Corr. for 
"blank" mg. 13.76 19.53 12.79 
























































































































Percentage of administered Progesterone or 
Pregnanediol recovered as Pregnanediol in 
the Urine. 














was administered in gelatine capsules. The results 
are given in Table 22 and compared with those obtained 
after administration of progesterone in Table 22(a). 
CONCLUáION: The results of this investigation are com- 
pared with those obtained after the administration of 
progesterone by two routes to the same subjects. There 
is a striking parallelism in the amounts of unconverted 
progesterone and preconverted ,progesterone (pregnanedio 
which are excreted in the urine as pregnanediol. It 
seems highly unlikely that this similarity would have 
been produced if the small amount of pregnanediol re- 
:covered in the present experiment was a result of 
incomplete absorption by the alimentary tract. The 
implication that the factors determining the amount of 
pregnanediol excreted in the urine operate after the 
conversion of exogenous, and possibly endogenous 
progesterone, to pregnanediol is worthy of considera- 
tion and is discussed in Section VIII. 
1) 
(b) Administration of Sodium Pregnanediol Glucuronidatd. 
Pure sodium pregnanediol glucuronidate (the 
trihydrate) isolated by the method of Sutherland and 
Marrian (:1946, 1947) was prepared by Miss Sutherland. 
The original intention was to dissolve ca.420 mg. of 
N &PG. 3H20 in ca. 30 ml. of 0.9;; saline (pyrogen free) . 
This would be equivalent to ca.250 mg. of pregnanediol 
and 5.0 ml. of the solution would contain 40 mg. 
pregnanediol. With heating and even after increasing 
Table 23. 
SODIUM PREGNAT?EDIOL GLUCUROT?IDATE I. M. (D.P.) 
Admin. Volume. Pregnanediol mg./24 hr. 















































































































































the proposed injection to 7.0 ml. the NaPG.3H20 would 
not go into solution, whereas it might reasonably have 
been expected to do so in aqueous solution. (The 
presence of the sodium chloride may have prevented this 
by a common ion effect). As it seemed unlikely that 
further dilution within the range of a reasonable 
injection dose would ensure solution of the NaPG3H20 - 
and this subsequently proved to be the case - it was 
decided to administer it as a suspension. Accordingly 
7 ml. of this suspension each containing 71.5 mg. of 
NaPG.3H20 and equivalent to 40.0 mg. of pregnanediol was 
injected intramuscularly on two successive days in one 
of the normal males (D. P.) previously studied. 
As has been found in the case of injection of other 
crystalline suspensions the site of injection became 
ainful and there was a febrile reaction - although the 
suspension was sterile and no inflammation ensured. 
he results are given in Table 23. 
ONCLUSION: The recovery of pregnanediol from the 
rine was approximately twice as great as had been foun 
f ter the administration of progesterone or pregnanediol 
this normal male. The figure was not as high, 
owever, as either of those reported by Yenning and 
rowne (1938, 1940). It seems reasonable to suppose 
hat this discrepancy is related to the form in which 
he glucuronide was injected. slower absorption and 
xcretion resulted from the administration of the 
uspension in our case than was found after the admin- 
69. 
:istration of "NaPg" by yenning and Browne. Destruction 
if 
during sterilisation is unlikely but/hydrolysis of 
the slowly absorbed material occurred in the tissues 
and pregnanediol was liberated, then lower recoveries 
as pregnanediol in the urine would be explained. 
THE EXCRETION of PREGNANEDIOL RESULTING from 
CNTINUED DAI Y ADMINIS 44 o _ s ONE. 
Data upon the excretion of urinary pregnanediol 
in the urine of subjects receiving daily administration 
of progesterone for more than a few days are not 
presented in the literature. yenning and Browne 
(1940) administered doses of the order of 10 mg. 
progesterone daily for four to eight days. The 
recoveries of pregnanediol glucuronide were low and 
irregular and no significant trend was observed in 
the pattern of excretion. 
Cope (1940) in a case of secondary amenorrhoea 
previously discussed (section iii) injected 10 ma. on 
the first of five days and 5 mg. on the remaining four 
days. Only doubtful traces of pregnanediol glucuron- 
:ide were detected during the first five days but 2.5 
mg. was determined on the sixth day. In a case of 
anovular menstruation 10 mg. of progesterone was 
injected on each of five consecutive days. Pregnanedi 1 
glucuronide was not detected in the urine on the first 
three days but small amounts, adding up to 1.5 mg. 
70. 
were detected on the fourth and fifth days. Cope 
offered the suggestion that there may be "a kind of 
saturation phenomena" under these conditions comparable 
to that described in the excretion of ascorbid acid 
taken by mouth. 
In the first two cases studied in the present 
work, progesterone was administered daily to two healthy 
postmenopausal women aged 65 and 72 respectively. 
Both women received 60 mg. daily, by intramuscular 
injection in subject F. , and orally by cap sins in 
subject N. After a control period, progesterone was 
administered daily for 18 days in subject F. and for 22 
days in subject N. Oestradiol Benzoate was adminis- 
tered (30 mg. daily) on the 11tE1 and 12th days of 
progesterone administration of the first experiment ana 
on the 15th and 16th days of progesterone administra- 
: tion in the second. The results are given in Table 
24 and compared in Fig. VII. 
CONCLUSION: In both cases a plateau of pregnanediol 
excretion was found corresponding to a conversion of 
progesterone to pregnanediol of the extent previously 
observed in other healthy postmenopausal women. This 
plateau level of excretion was not maintained, however, 
and after a time -lag of six days in subject F. and ten 
to twelve days in subject N. the excretion of pregnane- 
: diol began to rise. During the plateau period 
subject F. (intra- muscular) was excreting 9 'bp 10;; of 
the administered dose and this rose to 17.; by the 10th 
TABLE 24. 
CONTINUED I.M. ADMIN. of PROGESTERONE to POST- iIENOP. 





















































































































CONTINUED ORAL ADMIN. of PROGESTERONE to POST - 












- 2600 0.19 Frog. 60 1710 12.10 
0.15 mg. 12.40 
- 1860 0.23 
It 1315 15.75 0.20 
14.10 
Frog. 1350 0.21 
80 mg. 0.21 " plus 1300 15.00 
Oestra- 14.65 
If 1240 8.80 :diol 30 
¡ 
8.95 mg.I.Ivï. 
" " " 1680 16.10 1650 9.60 
9.75 16.00 
Prog. 1490 18.75 ' 
It 1170 10.50 60 mg. 19.10 
10.50 
It 1240 17.35 
't 1800 10.80 17.65 
10.75 
It 1360 20.40 
't 1630 10.00 20.15 
10.25 
u 1410 19.10 
t1 1110 11.05 18.85 
10.75 r 1300 20.50 
if 1350 10.50 20.65 
10.40 u 1630 19.90 
19.50 
11 1610 12.00 
1250 20.51 11.65 
20.60 
tt 1480 12.75 
1280 5.80 13. 00 
5.50 
It 1820 11.40 - 990 1.94 
11.75 1.91 




CONTINUOUS PROGESTERONE ADM /N. 
60 mg. daily, 
Post menopausal women: 
Al. age 72 yrs.: oral admin. 







g. N :_ Days. 
71. 
During the plateau period subject 1T. (oral) was excret 
ing about 17 to 18', of the administered dose daily anc 
this rose to about 25% by the 15th day. Subject N. 
was one of 'the postmenopausal controls and yielded a 
recovery of 15.98ïó in series (i) . This case therefor 
parallels closely that of the.male (J.P.) who produced 
14.7; on intramuscular injection and 17.4 to 19.6 on 
oral administration. 
After the injection of 30 mg. oestradiol benzoate 
in the first experiment .the pregnanediol continued to 
rise for two or three days although by smaller incre- 
ments than in the last days of the progesterone 
control period. On the second day after the second 
oestrogen injection the pregnanediol excretion fell 
sharply and continued to fall until it had reached a 
level of the same magnitude as the previous "platuea ". 
If this experiment could be confirmed an advance in 
our understanding of this problem «o u1d have been made 
Several considerations delayed an immediate attempt to 
repeat it. In the first place we recognised how 
fortunate we had been in our subject (F.) who allowed 
us to inject 6 ml. of oil into the buttock every 
morning for twenty six days with 12 ml. on the 15th an 
16th days. An attempt was therefore made to bbtain 
more concentrated solutions of the two hormones, and 
in the meantime an attempt was made to repeat the 
result (in subject N.) by oral administration of 
progesterone. A second consideration was doubt as 
72. 
to the desirability of injecting such large doses of 
steroids into healthy subjects. Oral administration 
seemed a more innocuous procedure, but this also had 
its disadvantages in that the experiment broke down 
completely should the patient vomit or fail to take 
a capsule. Furthermore, absorption from the alimentary 
tract might vary with the taking of 'alcohol or in 
reslionse to unknown dietetic conditions. 
With these considerations in mind the 
along the lines described above was carried out in 
subject N. That all the capsules were swallowed was 
ensured by watching this process in the home, and 
once more we were very fortunate in receiving so much 
co- operation. No conclusion can be reached at this 
stage as to the apparent lack of effect produced by 
Oestradiol, in this:experiment. This was chosen in 
place of benzoate to facilitate the estimation of 
oestro #ens in the urine and b ecause of its more rapid 
action. It is recognised however that the biological 
effect of the pure substance is less potent than that 
of the benzoate. Whatever the explanation, the 
pregnanediol excretion rose steadily and continued to 
rise for several days after the effect of the oestradiol 
must have passed off, and from the 19th to the 23rd 
days of the experiment a second plateau of about 34:-; 
was present. 
If the oestrogen had its biological effect in 
this experiment and yet did not affect the conversion 
73. 
of progesterone to pregnanediol then the explanation 
may lie in the choice of route of administration. 
Progesterone administered orally is stated to have ver 
little biological effect (Dorfman et al, 1948) and if 
the effect of oestrogen on the "priming" phenomenon is 
bound up with this biological effect u_aon certain 
tissues then it would not be surprising to find the 
two different responses exhibited by these two subject 
Before beginning a systematic investigation of 
this _possible interaction of progesterone and oestrogen, 
further studies on the "priming" phenomenon, obtained 
during the continued administration of progesterone, 
were carried out. These studies are still in _;rogres 
but the results of an attempt to reproduce this effect 
in men have just been obtained. 
The first male to be investigáted (J.M.) aged 30 
(Table 25) was given 40 mg. of progesterone daily by 
mouth for 18 days and determinations carried out daily 
and in duplicate. This smaller dose was tested in an 
attempt to reduce the cost of such experiments. Urine 
collection by this subject was exemplary and the resul 
is striking. The pregnanediol remained at a constant 
level of ca. 10 throughout this long period. Not on 
does this indicate that "priming" does not occur in 
this male - whereas the plateau level can be attained 
by male or female - but it is strong evidence against 
the possible view that the "priming" phenomenon 
results from saturation. A source of fallacy lay 
y 
74. 
however in the fact that this case received only 40 
mg. of progesterone daily, and accordingly, a second 
male (J. P.) was given 60 mg. of progesterone by mouth 
daily for 16 days. Throughout many experiments this 
male had consistently converted a highe- roportion of 
administered rogesterone to pregnanediol than had 
similar subjects. In the present experiment a level 
of about 19,;; - as in previous experiments - was produceld 
and this was maintained throughout the sixteen days. 
CONCLUSION: When progesterone was administered 
daily for more than about six days to healthy postineno- 
:pausal women, a rapid and progressive. rise in the 
proportion excreted as urinary pregnanediol resulted. 
There is a sugestion in the results obtained from 
subject N. that this rise continues until a second 
plateau of about 30.:.ä or more is reached. 
This effect was not observed in similar experi- 
:ments in young men. It seems unlikely that age is the 
vital factor but this has not been excluded. No 
direct evidence upon the role of the uterus is afforde 
by these experiments and a hysterectomised woman will 
be investigated. 
While definite conclusions cannot be drawn from 
this preliminary work on progesterone "priming" the 
results will be discussed and some speculation 





















































































To KALE ORAL ADI,,IN. of PROGESTERONE 
( J. M. ) 
(contd. ) 
Admin. Vol. PregnanediolI Admin. Vo1.IPre?nanediolj 
c. c. mg./24 hr. c. c. ',mg./24 hr. 
- 1890 0.29 40 mg. 1600 4.33 
0.21 Oral. 4.35 
- 1240 0.22 It 19001 4.60 
0.23 4.61 
40 mg. 2685 2.60 it 2350 4.10 
Oral 2.61 4.13 
It 3860 4.08 It 1600 '. 4.45 
4.20 4.50 
it 1520 4.20 it 2050 4.56 
4.13 4.57 
it 1510 4.60 It 1200 4.80 
4.59 4.72 
! 
If 1800 4.35 
1 




ti 2110 4.65 ` It 1200 4.62 
4.63 4.67 
it 1500 4.25 - 2540 0.92 
4.23 0.96 
tt 1900 4.37 - 1800 0.49 
4.35 0.43 
't 1250 4.29 - 2010 0.28 
4.30 0.24 
tt 2400 4.25 
4.27 
SECT /ON V. 
76. 
SECTION V. 
THE EFFECT of PROGESTERONE upon the EXCRETION 
of PREGNANEDIOL DURING N Y:AL PREGNANCY. 
The earliest observations on this subject were made 
by Yenning and Browne in 1940. These workers injected 
10 mg. of progesterone on the 44th,45th and 46th days 
of a normal pregnancy and later injected 20 mg. on the 
59th and 60th days of the same pregnancy- On both 
occasions a greater increase in pregnanediol excretion' 
resulted than was fb and in patients similarly injected 
in whom endogenous progesterone production was absent 
or very low. The first increase in excretion repres- 
:ented ca. 381;; of the injected progesterone and the 
second, ca. 5Oö. This observation was in accord with 
similar high recoveries obtained by these workers after 
the injection of progesterone during the luteal phase 
of the menstrual cycle. Yenning and Browne concluded 
that the recovery of pregnanediol from administered 
progesterone was greater when "all the normal mechan- 
:isms involved in its excretion are operative ". 
More recently, Davis and Fugo (1947) carried out 
a similar investigation in three normal pregnancies at 
about the 12th week. In two cases, 50 mg. was 
injected on each of four days and in the third case 
120 mg. was injected on one day. Pregnanediol 
determinations were infrequent and were determined by 
a semi -quantitative method (Davis & Fugo 1947), but 
76. 
these workers concluded that recoveries of additional 
pregnanediol were obtained which corresponded to 30 t 
35» of the injected progesterone. 
The view has been expressed by Guterman (1946) an 
subsequently by Bender (1948) that the administration 
of progesterone to pregnancies in which there is no 
sign of progesterone deficiency, as indicated by a 
"normal" level of pregríanediol excretion, tends to 
precipitate abortion rather than to afford additional 
prophylaxis against it. Influenced by this view, 
obstetricians were rather reluctant to allow us to 
investigate the effect of progesterone injection in 
normal pregnancy. Conversely it seemed undesirable to 
investigate the effect on abnormal cases. The dilemma 
was solved by the discovery of a women who was at the 
27th week of her 8th normal pregnancy and was found to 
be suffering from cardiac decompensation and mitral 
stenosis. It was considered inadvisable to induce 
therapeutic abortion by hysterotomy: at this stage of 
pregnancy, but had our investigation resulted in termin- 
ation of the pregnancy this would have been a satisfac- 
tory outcome. 
In experiments reported in Section VII very constant 
day to day excretion has been found in cases of 
pregnancy with normal levels, and even abnormal levels, 
of pregnanediol excretion. This is in accord with 
the findings of Bachman, Leekley and Hirschmann (1941) . 
With this in mind and with an approximate idea as to 
the duration of excretion resulting from two consecutive 
daily injections of 60 mg. progesterone, an attempt was 
made to carry out the experiment in five phases each 
lasting five days with progesterone administration 
during the second and fourth phases. In this way it 
was hoped that a calculation of the "additional" 
pregnanediol would be possible. To facilitate this, 
Creatinine excretion was determined daily by the method 
of. Folin and the daily excretion of pregnanediol 
corrected to the average creatinine value. As the 
patient was confined in a busy antenatal ward, 24 hour 
specimens were not always complete but as shown in Fig. 
IX, after correction in this way, a remarkably constant 
and slightly rising level of pregnanediol excretion 
was obtained. 
Results : - 
Day of Experiment. Total pregnanediol 
recovered. 
(1) 
1 - 5 .94. 20 mg. 
(A) 5 - 10 138.20 mg. 
10 - 15 98.40 mg. 
(B) 15 - 20 158.24 mg. 
20 - 25 112.40 mg 
(A) Theoretical endogenous yield during 1st 
administration 96.38 mg. 
Therefore pregnanediol derived from 
injection 41.90 mg. 
34.9% 









CONCLUSION: Previous studies on the effect of 
progesterone upon the excretion of pregnanediol in 
pregnancy have been confined to early pregnancy. The 
results in this case constitute a definite confirmation 
of such studies and extends their application into the 
.second and third trimesters of pregnancy. The tendency 
in the "priming" experiments to attain a similar extent 
of conversion of administered _progesterone to pregnane- 
:diol is of the greatest interest and possible implica- 









































































































































diol M . 
24 hr. 
corr. 




- 730 0.52 19.06 Prog. 980 0.47 19.16 
19.36 60 mg. ' 19.09 
I . M. 
900 0.50 19.22 " " 860 0.68 32.09 
19.28 31.90 
- 790 0.62 18.36 - 1060 0.63 41.50 
18.62 42.00 
Prog. 970 0.57 18.26 - 1500 0.67 33.48 




" " 1160 0.69 24.34 0 - 2480 0.63 26.75 
24.25 26.85 
- 990 0.55 41.04 - 2150 0.64 24.50 
42.41 24.75 
- 1130 0.67 27.55 - 2050 0.63 23.75 
28.32 23.40 
- 1180 0.58 22.95 ^ 2750 0.66 23.75 
23.31 23.81 
- 1400 0.68 21.16 - 2450 0.65 23.57 
21.06 23.76 
- 880 0.68 20.23 - 2100 0.63 22.85 
20.41 23.00 
- 1480 - 20.35 - 2360 0.65 23.04 
20.20 22.80 
- 825 0.45 19.95 
19.60 
SECT /ON VI. 
79. 
SECTION VI. 
THE EXCRETION of PREGNANEDIOL FOLLOWING EXCISION of th4 
CORPUS LUTEUM of PREGNANCY. 
Many cases of excision of the corpus luteum of 
pregnancy have been reported. In 1926, Ask- Upmark 
reported a series of fifty -one cases of excision of 
the corpus luteum during the first eight weeks of 
pregnancy in whom abortion followed in only seventeen 
cases. Pratt (1927), Douglass (1931) and Corbet (1932 
published similar accounts of the continuation of 
pregnancy after this excision in pregnancies not more 
advanced than the sixth week. On the other hand DeLe 
(1916) reported two cases followed by abortion and 
Wilson :1937) reported abortion following excision of 
the C.L. in five cases ranging from the fifth to the 
twelfth week of pregnancy. As pointed out by Jones 
and Weil (1938) the fact that abortion may or may not 
follow abdominal operation makes it difficult to asses 
the importance of removal of the. corpus luteum in such 
cases. 
While these findings are contrary to conclusions 
reached by Corner (1928) Robson (1937) and others who 
have studied the maintenance of Pregnancy in animals, 
species variation must not be overlooked. 
Considerable indirect evidence exists which 
indicates an extra -ovarian source of progesterone in 
pregnancy. (Newton 1935). Such evidence was provided. 
80. 
by the experiments of Haterius (1936) in which it was 
shown that pregnancy could be maintained in the ovar- 
:iectomised rat provided that all but one of the 
foetuses were removed while all the placentae were 
left in utero. whereas the presence of the ovary and 
corpus luteum are essential for the maintenance of 
pregnancy in the rabbit, this is less true of higher 
species and the implication is that this extra -ovarian 
source, which is probably the placenta, has acquired 
wider functions in the course of evolution. (Robson, 
1947). 
Attempts to detect progesterone in placental 
tissue or to detect the production of progesterone by 
placental cells grown in vitro (Jones, Gey and Gey, 
1943) (Stewart, Sano and Montgomery, 1948) have been 1 
unsuccessful. 
Strong evidence in favour of extra -ovarian proges- 
: terone production in pregnancy would be provided by the 
determination of pregnanediol in the urine of ovariect4 
:omised Pregnant women. Data are published concerning 
the determination of pregnanediol glucuronide by the 
method of Yenning in two cases following excision of 
the corpus luteum of pregnancy. 
Jones and Weil (1938) report the removal of the 
corpus luteum at the eighth week of pregnancy. 
Abortion did not occur and a normal living child was 
delivered at term. Pregnanediol determinations were 
detected for about twelve days subsequently but it then 
81. 
reappeared in the urine in increasing amounts. It 
seems probable that during the time when no pregnanediol 
glucuronide was detected, small amounts were in fact 
present in the urine but that these were not great 
enough to be detected by the Yenning method. 
yenning and Browne (1937) reported a similar case 
in which the pregnanediol fell to a low-level and then 
rose again to normal limits for the remainder of the 
pregnancy. (Details are not published). 
Cope (1940) reported a rather different case in 
that pregnanediol disappeared from the urine within 
five days of resection of the corpus luteum at the 
ninth week of pregnancy. Abortion followed several 
days later. 
The case investigated in the present work was a 
pregnancy at the ninth week. An ovarian cyst was 
present on the left side and torsion of its pedicle 
occurred with congestion of the left ovary and the 
C.L. of pregnancy. Intense pain resulted and the 
clinical picture resembled that of imminent rupture of 
tubal pregnancy. The whole of the left ovary and 
corpus luteum were removed. Pregnanediol determina- 
:tions were carried out daily until abortion occurred 
nine days after the operation. The results are shown 
in Table 26 and Fig X. Complete 24 hour urine 
specimens were not obtained in the first three days 
after operation, and the pregnanediol recovery on 
these days was corrected for the average daily 
82. 
excretion of creatinine which was 1.15 mg. /24 hr. 
CONCLUSION: For six days after the excision of the 
corpus luteum at the tenth week of pregnancy, a small 
but constant amount of pregnanediol was excreted in 
the urine. The pattern of excretion and the length 
of time during which this level was maintained exclude 
the possibility that this might represent clearance 
from the body of pregnanediol formed from progesterone 
produced by the corpus luteum. A fall in pregnanediol 
excretion occurred coincident with commencing detachment 
of the uterine contents and pregnanediol disappeared 
from the urine after their expulsion. The probability 
is that the pregnanediol determined was formed from 


























































































































rig. /24 hr. 
Pregnanediol 
mg. /24 hr. Corr. 
2 890 0.82 2.05 2.87 
1.96 2.77 
3. 640 0.97 2.25 2.66 
2.30 2.73 
4. 760 0.72 2.00 3.20 
1.95 3.11 
5 1840 1.23 2.49 2.31 
2.46 2.30 
6 2750 1.10 2.36 2.47 
2.29 2.39 
7 2100 1.13 1.89 1.92 
1.90 1.93 
8 1190 1.16 1.85 1.83 
1.78 1.76 
9 435 - 0.55 
0.93 





DIETHYLSTILBOESTROL ADMINISTRATION during PREGNANCY. 
Effect upon the urinary excretion of pregnanediol 
in normal and dfäbetic Pregnancy. 
In a series of papers published over the period 
1931 -1948, O.W. Smith and G. van S. Smith have develope d 
a theory concerning the interdependence of oestrogen and 
progesterone metabolism. These workers believe that 
oestradiol and oestrone are partly converted in the 
body into oestrogenically inactive oxidation products 
and that this conversion is favoured when there is 
progesterone deficiency. They further believe that 
these oxidation products stimulate the secretion of 
progesterone and other "sex- steroids ". (Smith and 
Smith, 1941). They suggest that this effect i4nediated 
in the non- jregnant woman by an increased secretion of 
pituitary gonadotrophin and in pregnancy by "increased 
utilization of chorionic gonadotrophin ". (1948). 
In the belief that oremature senility of the 
placenta with premature withdrawal of its hormonal 
secretion is a vital factor in the pathogenesis of such 
accidents of pregnancy as pre -eclampsia, these workers 
have found a therapeutic application for their earlier 
work in an attempt to modify this premature "syncytial- 
steroid" aberration in human pregnancy. Thus Smith, 
Smith and Hurwitz (1944) suggested that it might be 
possible to forestall an incipient deficiency of 
progesterone and oestrogen in pregnancy by administering 
sufficient oestrogen to supply an increased amount of 
stimulating oestrogen break -down _products. 
The finding by Smith andSmith (1944) that 
diethylstilboestrol is one hundred times more active 
than oestrone in stimulating the pituitary of the rat, 
suggested to them that the synthetic oestrogen might 
also be effective in stimulating a defective secretion 
of placental "sex- steroids" in pregnancy. 
To investigate this possibility, Smith, Smith and 
Hurwitz (1946) studied the urinary excretion of 
pregnanediol and endogenous oestrogen in a pregnant 
diabetic woman with a history of pre -eclampsia in her 
two previous pregnancies. Diethylstilboestrol was 
administered daily from the 17th to the 35th week, with 
intermissions at the 19th and 25th weeks. The dose 
administered daily rose from 30 mg. at the 17th week 
to 125 mg. at the 32nd week. During this time the 
excretion of urinary pregnanediol was determined on 
twenty occasions by the method. ofVenning (1937,193.8). 
The results appeared to be conclusive; during the 
periods when diethylstilboestrol was administered the 
pregnanediol excretion rose steadily and dropped each 
time it was withdrawn. It is noteworthy that the 
pregnanediol level during Periods of diethylstilboestrol 
administration was considerably higher than previously 
reported normal values (yenning 1938, smith and Smith 
1941, and Hain 1942). 
Smith, Smith and Hurwitz x,1946) suggest that the 
rise in ,, regnanediol excretion which follows the 
85. 
administration of diethystilboestrol is a result of 
stimulation of progesterone secretion. 
Moe recently, Davis and Fugo (1947) using a method 
of pregnanediol determination based on the procedures 
of Astwood and Jones (1941), Talbot et al (1941) and 
Guterman (1944, 1945) have studied the effect of large 
doses of diethylstilboestrol - from 50 mg. to 200 mg. 
daily - on pregnanediol excretion during early pregnancy. 
These workers claim that this treatment had no effect 
on the pregnanediol excretion. 
The observations ofDavis and Fugo (1947) were of 
especial interest since urinary pregnanediol was being 
determined after acid hydrolysis and not as its 
glucuronide. The data published by these workers is 
not, however, entirely convincing. The levels of 
pregnanediol excretion as determined by their method 
(1947) were more irregular than those observed by us 
in normal or abnormal pregnancy, and as control periods. 
prior to diethylstilboestrol administration are not 
included in their -publication, interpretation of the 
effect upon pregnanediol excretion is rather difficult. 
Smith and Smith (1948) criticising this work draw 
attention to the fact that the dosage employed was 
greatly in excess of their own recommendations and 
suggest that such large doses early in pregnancy may 
inhibit progesterone secretion by depressing the 
utilisation of chorionic gonadotrophin. 
In the present work the effect of diethylstilboes- 
:trol upon thF urinary excretion of pregnanediol has 
86. 
been studied in three diabetic pregnant women and one 
normal pregnancy. pregnanediol was determined by the 
method described in Section II. All determinations 
were carried out daily and in duplicate uon aliquot 
portions of 24 hour urine samples. 
The comA.eteness of all but a few of these 
specimens was indicated by a constant daily excretion 
of urinary creatinine as determined by the method of 
Folin (1914). The value of creatinine determinations 
upon the urine of women receiving sex hormone therapy 
has been discussed by 0.W. Smith (1942) . 
The dose of diethylstilboestrol the week of 
pregnancy during which it was administered, and the 
effect upon the excretion of pregnanediol are given 
in Figs. XI - XV and Tables 29 - 31. 
The normal pregnancy studied - subject D - was a 
primipara aged 30. It was interesting to note the 
high degree of tolerance to diethylstilboestrol which 
is found in pregnancy. No symptoms resulted from 
the administration of 50 mg. daily at the 14th week 
of pregnancy. Administration was repeatedat the 
22nd and 24th weeks of pregnancy. The pregnancy 
continued without mishap until the 40th week when a 
healthy male child was delivered. 
Subject H. was also a primipara aged 30. 
Diabetes P ,itllitus had been present since the age of fi 
and had been controlled by insulin during the inter- 
vening years. 
A diagnosis of diabetes mellitus was made during 
ve 
87. 
the previous pregnancy of subject P. That pregnancy - 
which occurred two years for to the one under 
investigation was terminated by the delivery of a 
large stillborn infant. Intrauterine death was 
suspected four days antepartum. Althouth diabetes 
was only recognised and insulin therapy commenced: 
during the first pregnancy, there was a definite 
history of thirst, oolyuria, boils, and pruritus, in 
preceding years. 
In subject B, diabetes mellitus was recognised 
and its control by insulin begun eleven years previous- 
ly. This patient's first pregnancy occurred two 
years previously, and was terminated by an intrauterine 
death five days antepartum. Her second pregnancy - 
one year later - was terminated by a miscarriage at 
the nineteenth week. 
CONCLUSION: The effect upon the excretion of 
urinary pregnanediol was unequivocal and was reproduced 
in all four cases studied. Administration of 
diethylstilboestrol resulted in a sharp fall in 
pregnanediol excretion. After withdrawal, the 
pregnanediol rose steadily or after a short delay (as 
in subject H.) This effect was produced by doses 
of diethylstilboestrol which were either greater than, 
less than, or similar to those advocated by smith and 
Smith. (A scheme of dosage was received by private 
communication with these workers). 
88. 
These results cannot be said to disprove those of 
Smith. Smith and Hurwitz (1946) since the conditions 
of the experiments c) uld not be identical but they 
appear to indicate that a fall in urinary pregnanediol 
is a common sequel to the administration of diethylstilJ- 
:boestrol in pregnancy and although some spontaneous 
elevation of the pregnanediol may occur during 
continued administration, this does not appear to 
constitute a rise even to normal levels. 
Possible explanations of the discrepancy between 
these findings and those of Smith, Smith and Hurwitz 
are discussed in Section VIII. 
M g/ 
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VISOR 2000 2.65 stilb. 2310 1.56 
2.69 50 mg. 1.53 
1870 2.56 It 2505 1.61 
2.60 1.59 
2470 2.93 tt 1995 1.68 
2.96 1.63 
2160 3.05 1810 2.00 
2.99 2.04 
2370 3.65 2560 2.44 
3.60 2.51 
2040 3.76 2340 1.89 
3.72 
1420 3.48 1320 1.90 
3.45 1.87 
stilb. 2650 3.90 1200 1.78 
50 mg. 4.00 1.78 
It 2200 2.80 1740 2.71 
i 
2.85 









DIETHYLSTILB. : DIABETIC PREGNANCY (P). 







Admin. Vol. Creat 'Pregnane- 
inine diol Prlg./ 
Gm. 124 hr. 
Corr. 
- 1550 - 18.4 " 2120 1.11 16.2 
17.3 16.8 
- 1370 0.94 19.6 " 1760 1.15 16.7 
19.2 17.1 
- 1290 1.21 17.7 " 1740 0.96 15.2 
17.3 14.5 
- 1040 0.82 18.0 " 1870 1.07 12.9 
17.9 13.1 
- 1980 1.14 15.3 " 1820 1.14 14.4 
14.7 14.7 
- 1600 1.16 16.6 " 1760 1.13 13.6 
17.3 13.4 
- 1280 1.03 1920 1.14 15.3 
17.2 15.5 
- 1340 1.04 18.9 - 1900 1.12 15.4 
19.7 14.9 
- 1760 1.23 17.7 - 1760 1.11 25.8 
17.1 25.5 
- 1900 1.15 17.9 - 1400 0.82 23.9 
18.0 24.1 
- 1920 1.11 19.4 - 750 0.95 20.3 
19.1 20.6 
Stilb 1590 1.17 19.7 - 1720 1.11 23.8 
30 ing. 18.8 23.4 
" 1820 1.19 20.9 - 1800 1.10 26.4 
21.5 26.2 
TABLE 31. 
DIETHYL3TILB.: FREGNíUJT DIABETIC (B.), 
Admin. Vol. Preg. 
c. c. mg./ 
24 hr. 
Admin. Vol. Preg. 









1360 5.50 2080 8.75 Stilb.2040 5.70 
5.55 9.00 30 mg 5.75 
2020 7.50 1850 9.13 " 2700 6.53 
7.58 9.33 6.26 
2095 6.75 2480 8.81 " 2565 6.00 
6.90 8.98 6.00 
2600 6.40 2500 9.70 " 2300 6.28 
6.15 9.88 6.30 
1700 7.18 Stilb.2580 10.25 " 1940 7.23 
7.00 25 mg. 10.43 7.08 
2205 7.08 " 1800 9.10 " 2465 7.08 
7.30 9.33 7.20 
2765 7.55 " 3620 5.99 - 2780 7.45 
7.38 5.45 7.25 




2290 8.13 " 2785 7.22 - 2480 9.85 
8.18 7.07 9.90 
2450 7.43 " 2630 7.28 - 2656 11.0 
7.63 7.08 11.15 
2600 7.75 " 2730 6.49 - 2625 10.6 
7.65 6.68 10.7 
2180 8.00 3ti1b.1980 7.58 - 2665 12.6 
8.05 30 mg. 7.23 12.2 
2565 7.95 " 2790 6.17 - 2750 12.0p 
7.88 5.73 12.19 




Certain assumotions are made when a Quantitative 
or ever_ a qualitative significance is attached to the 
amount of pregnanediol excreted in the urine of human 
subjects. 
The first assum3tion concerns the identity of th_e 
substance estimated. It can by no means be assumed 
that this is pregnanediol - whether that term be limited 
to pure y regnane- 3(ol),20d(-diol or be widened to includ 
a mixture of its stereoisomers. No routine method 
exists for the determination or ; regnane- 3(4),20,,( -diol 
separated from allopregnane- 3(c0,2034-diol and, in the 
discussion which follows, the term "pregnanediol" is 
applied to the group of pregnanediol compounds deter- 
:mined by thü method described in Section II. 
No method can be recommended for the determinatio 
of pregnanediol in urine containing very large amounts 
of neutral 17- ketosteroids or of other neutral steroid 
of adrenal origin. These were not present in the 
urines investigated in the present work nor would they 
be likely to cause serious interference in determina- 
tions in the menstrual cycle or in pregnancy. For 
routine determinations in pregnancy, for diagnostic or 
prognostic pruposes, a less specific method such as 
that described in section III may serve a useful 
purpose. 
Reference has already been made to methods for 
the determination of pregnanediol as its glucuronide 
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and to their comparative lack of specificity. It was 
almost inevitable that the a olication of such methods 
to clinical material would result sooner or later in 
fallacious interpretation. Thus the fact that a high 
degree of specificity is not a feature of the Yenning 
method affords one of several ,possible explanations 
for the discrepancy between the findings of smith and 
Smith and those reported in the present work, upon the 
effect of diethylstilboestrol administration on the 
excretion of pregnanediol in pregnancy. Diethylstil- 
:boestrol monoglucuronide has been isolated from 
human urine by Willia.:s (1948), and it cannot be 
assumed that sodium diethylstilboestrol glucuronidate 
did not contaminate the final product of the Yenning 
method in the investigation reported by smith, Smith 
and Hurwitz (1946) . The fact that this final 
precipitate contains sodium pregnanolone glucuronidate 
(Marrian and Gough, 1946) as well as pare sodium 
pregnanediol glucuronidate (Sutherland and Marrian, 
1946) constitutes another source of error in inter - 
:pretation. The possibility may be considered that 
under certain circumstances, progesterone metabolism 
may be influenced in such a way that the relative 
proportion of these two glucuronides in the final 
precipitate is significantly altered. Thus diethyl- 
: stilóoestrol mi ht conceivably lower the excretion 
of pregnanediol glucuronide and raise that of pregnano- 
:lone glucuronide to such an extent that a high result 
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be obtained by the Yenning method and a low result by 
the more specific method. 
Similarly, the awarent fall in the excretion of 
pregnanediol which 'occurred on injection of oestradiol 
benzoate after "priming" with progesterone (case F. 
Section Iv) might be accounted for by diversion of the 
metabolic pathway of lnrogesterone to metabolites other 
than pregnanediol. It would be interesting if such a 
change occurs under physiological conditions. Deter- - 
:mìnations are being carried out on the excretion of 
pregnanediol in normal pregnancy. As none of the 
pregnancies studied has as yet come to full term these 
results are not reported here, but already there is a 
suggestion that they are sir,nificaitly lower than thos 
obtained by the Yenning method and reported by Yenning 
(1938), Smith and Smith (1941), Bachman, Leekley and 
Hirschman_ (1941) and Hain (1942) . If this prelimin- 
ary observation.: is confirmed, contamination of the 
final product of the Yenning method by ketonic sodium 
glucuronidates would afford a partial exlanation. 
The possibility should perhaps be considered, however, 
that alterations in the.ratio of non -ketonic and 
ketonic glucuronides may be physiological phenomenon i 
pregnancy. Thus one might speculate that during 
pregnancy, and possibly under the influence of endoeno 
oestrogen, there is a progressive shift in the metabol- 
ism of progesterone from non -ketonic to ketonic metabo 
Investigation Of such a hypothesis awaits the elabora- 




pregnanolone glucuronidate in human urine. 
A second assumption is concerned with the sources 
of progesterone or its metabolites in the experimental 
subject. The possibilitythat extra- ovarian or even 
unsuspected sources of these compounds may be present 
in the body cannot be overlooked. 
Pregnanediol has 'been isolated from the urine of 
men by Westphal (1944) and of women with hyperplasia 
of the adrenal cortex by Yenning, Weil and Browne (1937 
Furthermore, Cuyler,. Ashley and Ha;;:blen (1940) and 
Horwitt, Dorfman, Shipley and Fish (1944) observed the 
appearance of pregnanediol in the urine after the 
administration of desoxycorticosterone to human subjects. 
Desoxycorticosterone may be produced and, of course, 
closely similar substances are ?roduced normally by 
the adrenal cortex. 
In the control periods of the investigations 
reported in the present work the apparent excretion of 
pregnanediol rard y exceeded 0.5 mg. per 24 hour 
specimen. . Furthermore, it is probable that a propor- 
tion of this "blank" reading was attributable to 
substances other than pregnanediol. Traces of neutral 
17- ketosteroids and other chromogenic steroids and 
traces of urinary pi merits which had survived the 
purification procedure would act as chromogens in the 
sulphuric acid reaction. It was unlikely, therefore, 
that significant amounts of progesterone were produced 
by the ovaries or adrenals of the post -menopausal 
women studied, in view of the control period "blank" 
) 
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values which were observed before and after each 
investigation. 
It may be mentioned in parenthesis that the work 
of Corner (1945) and Greulich (1946) indicates that 
the theca interna cells as well as the granulosa cells 
not only contribute to corpus luteum formation, but 
may exhibit luteinisation and progesterone formation 
prior to ovulation. 
Thus while it may be said that sources of 
progesterone formation other than the corpus luteum 
caused negligible interference in these quantitative 
studies, it is conceivable that in certain circum- 
stances such sources may be stimulated. 
The production of progesterone by the maturing 
placenta was implied by the maintenance of excretion 
of pregnanediol which occurred after resection of the 
corpus luteum of pregnancy, and the rapid disappearance 
of pregnanediol from the urine after detachment and 
expulsion of the uterine contents (;section VI.) 
A third assumption in the interpretation of urina 
pregnanediol excretion has arisen from the tentative 
su7gestion by Vennin and Browne (1938, 1940) that a 
parallelism exists between progesterone production and 
pregnanediol excretion. Their pioneer work demonstra- 
ted a striking qualitative relationship and established 
pregnanediol as an essential metabolite of progesteron 
but it could not be assumed that a simple quantitative 
relationship existed between progesterone production 
and pregnanediol excretion. mhis has been made, 
y 
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however, by other workers. Thus Smith, Smith and 
Hurwitz (1946) concluded that the rise in pregnanediol 
excretion which they observed following diethylstil- 
:boestrol administration was due to an increase in 
endogenous progesterone production, and the therapeutic 
indication for the administration of this drug in 
pregnancy was based upon that assumption. 
The experiments in the present work which were 
concerned with the conversion of administered progester- 
:one to urinary pregnanediol (Section IV), suggested, 
at First, that a proportion of i;he administered 
progesterone, approximately constant for a given 
individual, was excreted as pregnanediol in the urine, 
In men, in post -menopausal women whether normal, 
hysterectomised, or pretreated with oestrogen, this 
fraction remained within fairly narrow limits. If it 
could be assumed that exogenous progesterone is metabol- 
ised in the body in a similar manner to endogenous 
urogesterone - and direct evidence is not available on 
this important point - then it seemed possible that by 
a simple calculation, the approximate endogenous pro- 
duction could be interpreted from the excretion of 
pregnanediol of endogenous origin. This may, in fact, 
be justifiable where the body is under the influence of 
progesterone for short periods only, but the results of 
experiments on the continued daily administration of 
progesterone which are reported later in section IV, 
and the result of progesterone administration on the 
95. 
excretion of pregnanediol in normal pregnancy (Section 
V) throw a different light upon this relationship. 
It ap,ears that under the continuous influence 
of progesterone there results a progressive change in 
the proportion of administered progesterone excreted 
as pregnanediol. Furthermore, when progesterone is 
administered to an individual where endogenous proges- 
: terone production ii occurring, a much higher propor- 
: tion of the administered progesterone is excreted as 
pregnanediol (Section V). The results of the latter 
type of experiment when carried out in the menstrual 
cycle (Venning and Browne, 1940) as well as these 
obtained in pregnancy, are not directly opposed to the 
existence of a simple quantitative relationship since 
progesterone production is beyond the control of the 
observer and since exogenous progesterone may undergo 
a more complete reduction to pregnanediol in the 
presence of excess endo -enous progesteone. On the 
other hand, it is of especial interest to find a 
progressive increase in pregnanediol eAicretion result- 
ing from the conversion of progesterone from a consta 
source in subjects in whom endogenous production is 
absent or minimal. The ultimate extent of conversion 
which would result from very prolon --ed administration 
of progesterone cannot be deduced from these prelimina-y 
experiments since the excretion of pregnanediol was 
rising rapidly at the time of administration of oestro en, 
but it may . e that a progressive change of this type 
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represents the physiological relationship between 
progesterone production and pregnanediol excretion 
when endogenous progesterone production is prolonged 
as in pregnancy and to a less extent in the menstrual 
cycle. The effect of oestrogen upon this phenomenon 
was therefore of especial interest. The administratio: 
of oestradiol benzoate appeared to abolish the "priming 
effect whicA resulted from intra- muscular administratio 
of progesterone, but the administration of oestradiol 
had less effect on the "priming" which resulted from 
the administration of progesterone by mouth. The 
latter investigation must be neglected for the present 
purpose as it contains too many variables for interpre- 
tation, but the former implies a limitation of this 
spontaneous progesterone ";.riming" phrnomenon by 
oestrogenic influences. If this is confirmed then it 
mig=ht find a place in a speculative translation of - 
these finding ;s to endogenous metabolism. It may be 
that the extent of conversion of endogenousprogesteron 
in pregnancy is limited in accord with the production 
of endogenous oestrogen or of its metabolic _products. 
The possible influence of the uterus upon the 
metabolism of progesterone has been the subject of 
considerable controversy. The results of previous 
workers have been reviewed in ;3ection IV. The results 
of Jones and Telinde (1941) and of the present work sho 
that the _cost- menopausal uterus does not play an 
important part in the conversion of administered 
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orogesterone to urinary )regnanedi ©l' but do not excl ud 
the possibility that a greater extent of conversion 
may occur in the presence of t e :ihysiolocically activ 
uterus. On the other hand Pretreatment with oestrog 
resulting in two cases in the development of prolifer- 
:ative endometria, also did not affect the >>ercentage 
conversion by post -menopausal women. Approaching th 
problem from a different angle, Davis and Fugo (1948) 
have investigated the menstrual cycle of twelve young 
women in whom total hysterectomy has been performed. 
Ovulation was indicated by a typical rise in the basal 
temperature and although pregnanediol determinatio: :ls 
were infrequent these workers state that the "luteal 
phase" was of normal duration with pregnanediol 
excretion ranging from 5.0 to 17.0 mg. per 24 hour 
specimen. 
With these considerations in mind, it was perhaps 
surprising to find that the ,progesterone "priming" 
phenomenon was not observed in men following continued 
progesterone administration by mouth. This requires 
further investigation, however, since many factors 
_other than the absence of the uterus might be respons- 
: ible, and the "priming" phenomenon following proges- 
terone administration by mouth to the _post- menopausal 
woman (N) must be confirmed. 
Conflicting reports are found in the literature 
concerning the possible function of the liver in the 
metabolism of progesterone. Kochakian et al (1944) 
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implanted pellets of progesterone in various sites in 
the rabbit and concluded that the liver was the chief 
site of inactivation. Selye (1941) and Selye and 
Stone (1944) observed that the anaesthetic action of 
progesterone administered orally to the rat is greatly 
enhanced by partial hepatectomy. This anaesthetic 
effect was aoparent in one of our cases - the post- 
menopausal woman receiving 60 mg. of progesterone 
orally daily for three weeks (subject N4 Section IV) , 
who became progressively more drowsy from the tenth 
day of the investigation. That the term "progesterone" 
anaesthesia" is justifiable was indicated by the 
studies on the brain potentials of rats by Hartman et 
al (1947). 
In 1945 Masson & Hoffman compared the effect upon 
the rabbit endometrium of progesterone administered 
subcutaneously or by gavage. These workers found tha 
400 to 800 times the effective subcutaneous dose 
was required to produce progestational changes 
following oral administration and furthermore that 
the lime eff'et could be obtained with one -eightieth 
of this intragastric dose following partial he:)atectom,. 
Masson & Hoffman concluded that progesterone adminis- 
tered by this route is absorbed and inactivated by 
the liver before reaching the endometrium. A compari 
:son of the excretion of Jrogesterone by oral or 
intramuscular route had not been reported and the 
finding, in the present work, of a similar fraction 
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of pregnanediol after administration by either route 
supported some of these observations on animals, 
although it was not .possible to study biological effec 
in our (male) subjects. In view of the reproducib- 
ility of the effect, it seems unlikely that poor 
absorption from the gut explains the ineffectiveness 
of orally administered progesterone but it is just 
conceivable that reduction of the progesterone occurre 
in the gut and that it was absorbed as pregnanediol. 
A satisfactory method for the determination of minute 
amounts of progesterone would be of the greatest value 
in this connection. 
The similar outcome following the oral administr 
:tion of pregnanediol suggests that the factors limiti 
the proportion of administered progesterone excreted 
as pregnanediol operate after the conversion of a larg 
proportion of the administered progesterone to pregnan 
:diol, which then undergoes further metabolic change. 
These observations, therefore, tend to attract attentio 
to possible metabolites of progesterone of which 
pregnanediol may be an intermediary. One such theoretic 
possibility is the pregnanetriol isolated from urine of 
women with the adreno -genital syndrome by Butler & 
Marrian (1937, 1938). such findings also stimulate 
investigations upon the excretion of pregnanediol by 
routes other than urinary. Allouregnanediol has been 
isolated from ox -bile by Pearlman (1946) and pregnanedi 
has been isolated from human bile after oral administra 






possible excretion by this route of pregnanediol 
derived from progesterone have been delayed by technic 1 
difficulties. 
Furthermore, there is the implication that the 
important factors determining the extent of conversion 
of progesterone may be involved less with its metaboli 
reduction than with the conjugation of pregnanediol 
with h glucuronic acid. It is not difficult to 
visualise a role, hydrolytic, synthetic, or dual, for 
the enzyme glucuronidase in this process. The 
evidence in the present work, obtained from the 
investigations of abnormal cases - recently hysterect- 
:omised and hypertensive, and the demonstration of the 
progesterone "priming" phenomenon, clearly indicate 
that markedly different levels of excretion of urinary 
pregnanediol may follow the administration of the same 
dose of progesterone. Thus factors influencing enzyme 
activity in the liver and in other tissues, may be as 
important as these influencing hormone production in 
determining the amount of urinary pregnanediol derived 
from endogenous and exogenous _progesterone. 
With this in mind, and while extending these 
investigations upon clinical material, priority will be 
given in future work to an attempt to s tudy the 
biochemical processes involved in the conjugation of 
pregnanediol with special reference to enzyme activity. 
If progress is made in such studies, it may be 
possible to commence interpretation of the vast amount 
101. 
of data which is accumulatin< concerning the excretion 
of urinary .oregnanediol by human subjects in health 
and disease. 
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THE QUANTITATIVE DETERMINATION OF SMALL 
AMOUNTS OF PREGNANEDIOL IN HUMAN URINE 
BY I. F. SOMMERVILLE, NANCY GOUGH AND G. F. MARRIAN, 
From the Department of Biochemistry, University of Edinburgh 
(Received 27 September 1947) 
Various methods have been described for the quantitative determination of preg- 
nanediol in human urine. Of these the original procedure of Yenning [1937, 1938], in 
which sodium pregnanediol glucuronidate is extracted from the urine and weighed 
after purification, is still perhaps the most widely employed. This method, although 
somewhat time -consuming and laborious, gives satisfactory results when applied to 
urines containing more than c. 10-15 mg. of pregnanediol per 24 hr., but suffers from 
certain serious disadvantages where urines containing smaller amounts of the steroid 
are concerned. Thus, as pointed out by Astwood & Jones [1941], `when only small 
amounts of material are present in the urine, the identity of the final product is some- 
times questionable '. Furthermore, it may be necessary to use a full 24 hr. or even 
a 48 hr. specimen of urine for a single determination in order to obtain sufficient of the 
glucuronidate to weigh accurately. 
Other methods of determining pregnanediol as its glucuronide have been described 
by Allen & Viergiver [1941], Jayle, Crépy & Wolf [1943], and Bisset, Brooksbank & 
Haslewdod [1947]. These methods would seem to be somewhat less laborious and 
considerably more sensitive than the Yenning method, but they are open to criticism 
on the grounds of lack of specificity. A further disadvantage of all methods in which 
pregnanediol is determined as its glucuronide arises from the fact that, unless very 
special precautions are taken, hydrolysis of the latter by bacterial action may occur 
during the collection of the urine and subsequently. 
A method of a different kind was developed by Astwood & Jones in 1941. In this 
method the urine is boiled with acid to hydrolyse the glucuronide and the free preg- 
nanediol thus liberated extracted with toluene, purified and weighed. The originality 
of this method lies in the procedure used for the purification of the pregnanediol in the 
crude toluene extract. It was shown that from the toluene -soluble fraction, after 
removal of acidic substances by treatment with sodium hydroxide, nearly pure 
pregnanediol in almost quantitative yield can be obtained by precipitation from 
ethanolic solution with four volumes of water or dilute sodium hydroxide solution. 
The sensitivity of this method was considerably increased subsequently by Talbot, 
Berman, MacLachlan & Wolfe [1941], who estimated the purified pregnanediol colori- 
metrically by means of the yellow colour which it yields with concentrated sulphuric 
acid. Both groups of workers reported reasonably satisfactory recoveries of about 
70 % in short series of experiments in which sodium pregnanediol glucuronidate was 
added to men's urine in varying amounts,* but the evidence that either procedure 
* It seems possible that the recoveries obtained by these authors may actually have been somewhat 
higher than they themselves reported, since Marrian & Gough [1946] have shown that sodium preg- 
nanediol glucuronidate prepared and purified in the usual way [yenning & Browne, 1936] contains only 
about 80% of that compound. 
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would be dependable when applied to urines containing less than c. 10 mg. of preg- 
nanediol per 24 hr. was not entirely satisfactory. 
A somewhat simplified version of the Astwood & Jones method as modified by 
Talbot et al: has recently been developed by Guterman [1944, 1945] for the detection 
of pregnanediol in urine as a rapid means of diagnosing pregnancy. 
What will for convenience be called the Astwood- Talbot' method has several 
advantages over other methods of determining urinary pregnanediol. The colour 
reaction which pregnanediol gives with concentrated sulphuric acid is extremely 
sensitive, thus permitting the accurate determination of small amounts of the sub- 
stance; and although it is not a specific reaction for pregnanediol it was shown by 
Astwood & Jones and by Talbot et al. that many of the other urinary substances 
which give it are largely eliminated in the ethanol -water precipitation process of 
purification. Since the pregnanediol is determined in the free state, elaborate pre- 
cautions to avoid bacterial hydrolysis of the glucuronide in the urine are unnecessary. 
The objective of the work described in this paper was to develop an accurate, 
specific, convenient and rapid method for the determination of the pregnanediol 
(1 -10 mg. /24 hr.) in the urine of women during the luteal phase of the menstrual 
cycle. Furthermore, in order to permit duplicate determinations of pregnanediol and 
of other urinary constituents to be carried out it was necessary that the method 
developed should require not more than one -fifth or one -quarter of a 24 hr. specimen 
of urine. 
This objective has been nearly, but not quite, attained. A procedure based on the 
Astwood- Talbot method has been elaborated which permits of the reasonably accurate 
determination of more than c. 0.4 mg. of pregnanediol in one -fifth of a 24 hr. urine 
specimen. Six determinations can be completed in two 8 hr. working days, and the 
method is such that it could be satisfactorily employed by a trained and competent 
laboratory technician. 
APPARATUS AND MATERIALS 
Quickfit & Quartz glassware, with interchangeable standard glass joints, was used 
throughout in order to avoid contamination of the urinary extracts with coloured or 
chromogenic material that might be dissolved out of rubber or cork stoppers. 
The toluene used for the extractions was `sulphur -free' and was 'distilled before use. 
Ethanol was purified by refluxing over sodium hydroxide and distilling twice. 
Pregnane -3(a), 20a -diol was prepared from human pregnancy urine and purified 
via its diacetate. The sample used in the recovery experiments melted at 236- 
237° (corr.). 
Sodium pregnane -3(a), 20a -diol glucuronidate was prepared from human pregnancy 
urine by the method of Venning & Browne [1936] and freed from ketonic glucuronides 
by the method of Sutherland & Marrian [1946, 1947]. The preparation used in the 
recovery experiments melted at 282 -283° (corr.) with decomposition and evolution of 
gas. Samples of the glucuronidate were weighed out after exposure to moist air. As 
shown by Sutherland & Marrian [1947] material so treated is the trihydrate having the 
composition C27H08Na.3H20. 
For certain of the recovery experiments the toluene -soluble neutral fraction of acid - 
hydrolysed men's urine was required. This was prepared in the following way 24 hr. 
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urine specimens from a number of normal men were pooled and heated to boiling, 
together with some toluene, acidified with one -tenth of its volume of concentrated 
. hydrochloric acid, and the boiling continued for 10 min. After cooling the mixture was 
extracted three times with one -fifth volumes of toluene, emulsions being broken by 
filtration through a Buchner funnel with gentle suction. The - combined toluene 
extracts were washed twice with one -sixth volumes of N sodium hydroxide, three 
times with one -sixth volumes of water, evaporated to a small volume on a hot plate, 
and finally taken to dryness under reduced pressure in the water -bath. The brown 
gummy material so obtained will be referred to as `male urine neutral fraction'. 
MODIFICATIONS MADE IN THE PROCEDURES OF ASTWOOD AND TALBOT 
In consequence of a very large number of preliminary experiments, the details of all 
of which are not reported here, a number of modifications have been made in the 
original procedures as described by Astwood & Jones [1941] and by Talbot et al. 
[1941]. These modifications were designed to minimize the number of transferences 
from vessel to vessel during the procedure and to facilitate the rigid standardization of 
technique which experience has shown is essential if accurate and reproducible 
results are to be obtained with urines containing less than c. 10 mg. of pregnanediol 
per 24 hr. urine volume. 
Removal of acidic substances 
Astwood & Jones and Talbot et al. removed acidic and phenolic material from the 
toluene extract of the hydrolysed urine by boiling with methanolic sodium hydroxide 
and then filtering off the result ix precipitate of sodium salts. In the experience of 
the present authors it is equally effective and much simpler to remove acidic and 
phenolic material by washing the toluene extract in a separating funnel with aqueous 
sodium hydroxide. 
Purification of pregnanediol from the neutral fraction by precipitation from ethanol 
The accuracy and specificity of the Astwood- Talbot method are very largely 
dependent upon the efficiency of the precipitation process in separating pure preg- 
nanediol quantitatively from the neutral toluene- soluble fraction of the hydrolysed 
urine. Accordingly, considerable attention has been paid in the present work to 
investigating the optimal conditions for carrying out the precipitation and for 
collecting the precipitated pregnanediol. 
Collection of the precipitated pregnanediol. In the Astwood & Talbot procedures and 
also in the method of Guterman [ 1944] the precipitated pregnanediol was collected by 
filtration. To facilitate the quantitative collection of the small amounts of precipitate 
and in order to avoid as far as possible transference of the material from vessel to 
vessel, the precipitation process in the present work has been carried out in centrifuge 
tubes and the precipitate collected by centrifugation. At first some difficulty was 
experienced in getting the relatively light pregnanediol crystals to pack sufficiently 
tightly in the tubes to permit the siphoning -off of the supernatant solution. This 
difficulty was, however, overcome by adding to the precipitation mixture before 
centrifugation a small amount of the filter -aid Hyflo -Super Cel', which effectively 
entrained the precipitated pregnanediol. 
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Number of precipitations and volume of precipitatipn mixture. Astwood & Jones 
[1941] purified the pregnanediol from the neutral fraction by one precipitation with 
four volumes of N /10 sodium hydroxide followed by one with four volumes of water. 
Talbot et al. [1941] and Guterman [1944] used a single precipitation with four volumes 
of N /10 sodium hydroxide. In the experience of the present authors, however, one 
precipitation with sodium hydroxide and two with water are required in order to 
obtain the pregnanediol in a satisfactory state of purity. This multiple precipitation 
technique lengthens the process somewhat, but the loss of time is more than com- 
pensated for by the resulting increase in specificity which results. 
Numerous preliminary experiments showed that the most satisfactory results were 
obtained when the neutral fraction from one -fifth of a 24 hr. specimen of urine was dis- 
solved in 4 ml. of ethanol and precipitated with 16 ml. of N/10 sodium hydroxide or water. 
Rate of cooling after precipitation in hot solution. The efficiency of the precipitation 
process has been studied in many series of recovery experiments in which varying 
amounts of pure pregnane -3(a), 20a -diol were added to quantities of male urine 
neutral fraction ' each corresponding to one -fifth of a 24 hr. urine specimen. In the 
early experiments of this kind it was found that satisfactory recoveries (80 % or 
better) were obtained when more than about 4 mg. of pregnanediol were present 
(corresponding to 20 mg. /24 hr.), but that with smaller amounts of pregnanediol the 
recoveries were very much lower and very irregular. 
The great irregularity öf the recoveries suggested that some important variable 
factor in the purification process was not being properly controlled. Since the rate of 
cooling of the mixture after precipitation in hot solution might be expected to de- 
termine the size of the pregnanediol crystals it seemed possible that this might be the 
uncontrolled factor. 
This possibility was investigated in two series of recovery experiments in which 
varying amounts of pure pregnane -3(a), 20a -diol were added to portions of male 
urine neutral fraction ', each of which was equivalent to one -fifth of a single 24 hr. 
specimen. The pregnanediol in these mixtures was purified by the triple precipitation 
procedure, which was as described below (p. 252) with the exception that the cooling 
conditions following each precipitation were varied.. In one series of experiments the 
precipitation mixtures were cooled rapidly by immediate immersion in an ice -bath 
and were then left in the refrigerator overnight before centrifugation. In a second 
series, which were duplicates of the first, the mixtures were cooled slowly by trans -_ 
ferring them in beakers of water at 75° to an incubator at 37° where they were allowed to 
remain for 2 hr. They were then cooled in the refrigerator for 30 min. and centrifuged. 
The results *, which are shown in Table 1, are quite conclusive. It will be seen that 
rapid cooling of the precipitation mixtures gave lower and much more irregular 
recoveries of pregnanediol than were Obtained by the slow- cooling technique. It will 
also be seen that the difference in recovery due to the rate of cooling was most marked 
with amounts of pregnanediol corresponding to less than c. 20-25 mg. /24 hr. 
Later experiments, which are not reported here, have shown that the recoveries by 
the slow -cooling technique are unaffected by the omission of the short period of . 
refrigeration before centrifugation. It has also been found that a longer period at 37° 
A preliminary paper dealing with these findings was read to the Society for Endocrinology on 29 May 
1947. 
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than 2 hr. does not lower the recoveries. In the method finally adopted (p. 252) the 
actual periods during which the precipitation mixtures are incubated have been . 
adjusted to fit a working day of convenient length. 
Table 1. The effect of varying the rate of cooling after precipitation on the 
recovery of pregnanediol added to `male urine neutral fraction' 
Pregnanediol recovered 
corrected for `male 
urine blank' ( %) 
























Pregnanediol recovered (mg.) 
Rapid Slow 
Rapid cooling Slow cooling cooling cooling 
0.056 0.056 
0.012 0.031 0.055 0.050 
0.026 0.040 
0.017 0.0401 
0.015 0.014 0.042 J} 0.040 
0.010 0.037 
0.032 0.023 
0.012 0.023 0.092 0.096 0 17 
0.025 0.072 
0.016 0.33 
0.021 0.017 0.38I. 0.34 1 75 
0.015 0.31 
0.421 0.46 
0.42 J} 0.41 0.46 0.49 66 84 
0.37 0.57 
0.82 0.821 
0.82 0.75 0.82 } 0.84 89 99 
0.80 0.83 
4.0 4.2 
3.93.5 4.114.1 86 101 
2.5 4.0 
In view of these findings it is of some interest to consider the precipitation and 
cooling techniques of previous workers who have used the Astwood- Talbot method. 
Astwood & Jones [1941] do not appear to have controlled the temperature at which 
precipitation was carried out very exactly, but they did allow the precipitation 
mixtures to cool to room temperature before cooling in the refrigerator. Such a 
procedure in an American laboratory, where `room temperature' may be 25° or more 
might be said to provide `slow cooling'; in the average British laboratory in winter 
time, however, the procedure might very well give quite rapid cooling. Neither 
Talbot et al. [1941] nor Guterman [1944] controlled the temperature of precipitation, 
and since in both cases the precipitation mixtures were transferred directly to the 
refrigerator or into an ice -bath, their procedures must have undoubtedly involved 
rapid cooling. It can be concluded that the procedures used by all these workers would 
be liable to give low and erratic results with urines containing less than c. 20 mg. of 
pregnanediol per 24 hr. 
Sulphuric acid colour reaction 
The finally purified pregnanediol obtained by the precipitation process from the, 
urine of pregnant and of non -pregnant women has occasionally been found to be 
contaminated with traces of a blue pigment. The nature of this pigment has not been 
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investigated, but it is suspected that it may be of dietary origin. The presence of this 
pigment seriously interferes with the sulphuric acid colour reaction and it is therefore 
necessary to remove it before carrying out the reaction. This can be effectively done 
without loss of pregnanediol by warming in ethanolic solution with, charcoal. In 
order to maintain a rigid uniformity in procedure this treatment with charcoal has 
been adopted as a routine whether the pigment is present or not. 
Talbot et al. [1941] carried out the colour reaction by allowing the purified preg- 
nanediol to stand with 10 ml. of concentrated sulphuric acid at room temperature for 
20 min. In the present work, in order to standardize conditions as far as possible, the 
colour development has been carried out in a water -bath at 25° instead of at `room 
temperature'. 
METHOD FINALLY ADOPTED FOR THE DETERMINATION OF PREG}NANEDIOL IN URINE 
A 24 hr. specimen of urine collected with 5 ml. of toluene as preservative is made up 
to 2500 ml. and duplicate 500 ml. samples removed. Each sample is treated as 
follows : It is placed in a 1000 ml. flask and after the addition of 100 ml. of toluene 
brought to boiling point under a reflux condenser. To the boiling mixture is added down 
the condenser 50 ml. of concentrated hydrochloric acid (A.R.), and the boiling continued 
for exactly 10 min. The flask is then rapidly cooled in cold water and the contents 
transferred to a separating funnel of 750 ml. capacity. After shaking and allowing the 
urine layer to separate, the latter is run off into the original flask and the layer of 
toluene and emulsion filtered with gentle suction through a Whatman No. 1 paper on 
a Buchner filter funnel. The urine layer is then returned to the separating funnel and 
extracted twice more with 100 ml. portions of toluene, each toluene and emulsion 
layer being filtered in succession through the same filter funnel. The combined 
filtrates are then transferred to a clean separating funnel, and after running off the 
small urine layer that separates, the toluene extract is washed twice with 100 ml. 
portions of N sodium hydroxide and twice with 100 ml. portions of water. The 
washed toluene extract is run into a 500 ml. round -bottomed flask and is evaporated 
nearly to dryness on an electric hot plate and then taken completelyy to dryness under 
reduced pressure on a boiling -water bath. 
The dry residue is transferred quantitatively with warm ethanol to a 20 ml. 
conical centrifuge tube and the ethanolic solution evaporated to dryness in a water - 
bath under a stream of air. To the residue in the tube are added exactly 4.0 ml. of 
ethanol and the tube is placed in a beaker of water maintained at 75 °. After stirring 
with a glass rod for 1 min. to obtain complete solution, 16.0 ml. of N /10 sodium 
hydroxide are added drop -wise from a burette during 3 min. with stirring, the last 
1 ml. being used to wash down the stirring rod into the tube. After a further 1 min. at 
75 °, the beaker of water containing the tube is transferred to an incubator at 37° and 
left overnight. Approximately 8-10 mg. of Hyflo -Super Cel' (Johns- Manville Co. 
Ltd.) are added and "the mixture stirred with a glass rod. The rod is washed down into 
the tube with 1 ml. of a 1 : 4 (v /v) ethanol -water mixture and the tube is then centri- 
fuged for 1 hr. (1500 r.p.m. ; radius of 'centrifuge head : 15 .cm.). The supernatant 
solution is finally sucked from the precipitate with the aid of a fine glass tube attached 
to a slowly running water -pump. 
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The second and third precipitations are carried out as described above, except that 
water instead of sodium hydroxide solution is used, and the incubation periods are 
reduced for convenience to 2 hr. No additional filter -aid is added before the centri- 
fugations following the second and third precipitations. 
To the final precipitate are added 5 ml. of ethanol and the pregnanediol dissolved 
by warming with stirring at about 75 °. Norite' charcoal (c. 1 -2 mg.) is then added and 
the warming continued for 2 min. The mixture is filtered through a small filter 
(Whatman No. 1 paper) into a test -tube of 1 in. diameter, the centrifuge tube and 
filter being washed three times with 2 ml. portions of warm ethanol. The filtrate and 
washings in the tube are evaporated in a water -bath under a stream of air and the 
residue finally dried by leaving the tube in a va uum desiccator over calcium chloride 
for several hours. 
The colour reaction is carried out with not more than c. 0.5 mg. of the finally 
purified product. If, therefore, the amount of the latter appears on inspection to be 
in excess of 0.5 mg. a suitable aliquot portion is removed after solution in a known 
volume of ethanol. To the dry pregnanediol 10.0 ml. of concentrated sulphuric acid 
(A.R.) are added from a burette, and the tube is left in a water-bath at 25° for 20 min. 
with occasional shaking. The intensity of the yellow colour produced is measured in 
a Spekker' photoelectric absorptiometer using a `spectrum violet' No. 601 light 
filter. 
The absorptiometer readings are interpreted by reference to a calibration curve 
made with known amounts of pure pregnane -3(a), 20a -diol varying from 0.1 to 0.5 mg. 
It is advisable to construct a fresh calibration curve for each batch of unknowns. 
RECOVERY EXPERIMENTS 
The accuracy of the finally adopted method was tested in a long series, of recovery 
experiments in which pure sodium pregnanediol glucuronidate was added in varying 
amounts to men's urine. The validity of such tests, of accuracy depends upon 
two assumptions : (a) that all the pregnanediol in human urine is present as the 
glucuronide, and (b) that women's urine contains no substances which are not present 
in men's urine which would interfere with the determination of pregnanediol. Further 
work will be necessary to see whether these assumptions are justifiable or not. 
Twelve 24 hr. specimens of urine were collected from four normal men. Each 
specimen was made up to 2500 ml. and four 500 ml. samples removed. To each of two 
of these samples was added an identical amount of sodium pregnanediol glucuronidate 
dissolved in 80 % ethanol, the other two samples being retained for working -up as 
`male urine blanks'. All four samples from each specimen were then treated as 
described in the preceding section (pp. 252, 253). The results, in Table 2 show that a 
pregnanediol content of c. 2 mg. /24 hr. is. a critical one, above which recoveries are 
excellent, but below which they are poor. 
That the loss of pregnanediol when less than c. 2 mg. /24 hr. is present in the urine 
occurs mainly during the precipitation process rather than during the hydrolysis or 
extraction seems to be clear from the results shown in Table 1. This loss must be 
largely due to an effect of other substances in the neutral fraction upon the solubility 
of pregnanediol in 20 % ethanol, since experiments in pure solution have shown that 
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80-95 % of pregnanediol can be removed after the triple precipitation process when it 
is present in amounts corresponding to as little as 0.5 mg. /24 hr. It is possible, there- 
fore, that the critical concentration of pregnanediol below which recoveries are un- 
satisfactory may vary somewhat with different urines. However, the results reported 
here with a number of different specimens of men's urine suggest that this critical 
concentration is probably not far from 2 mg. /24 hr. in the majority of cases. 
Table 2. Recovery of pregnanediol after the addition of sodium 




`Male urine blank' 
as apparent 
pregnanediol in 
I of 24 hr. 
specimen (mg.) 




to } of 24 hr. 
urine specimen 
(mg.) 









' ( %) 
C4 0.016 0.2 0.017 0.001 0 
0.2 0.012 - 0 
A3 0.008 0.2 0.021 0.013 7 
0.2 0.047 0.039 20 
B2 0.024 0.2 0.060 0.036 18 
0.2 0.045 0.021 11. 
D4 0.035 0.4 0.32 0.29 72 
0.4 0.33 0.29 , 74 
B 3 0.015 0.4 0.28 0.27 67 
0.4 0.29 0.28 69 
A2 0.018 0.4 0.35 0.33 82 
0.4 0.35 0.33 82 
A4 0.044 1.0 0.99 0.95 95 
1.0 0.98 0.93 93 
C3 0.019 1.0 0.94 0.92 92 
1.0 0.96 0.94 94 
D2 0.077 1.0 1.0 0.92 92 
1.0 0.98 0.90 90 
B4 0-030 2.0 1.9 1.9 95 
2.0 2.0 2.0 100 
D3 0.017 2.0 2.0 2.0 100 
2.0 1.9 1.9 95 
C2 0.026 2.0 1.9 1.9 95 
2.0 1.9 1.9 95 
SPECIFICITY OF THE METHOD 
The sulphuric acid colour reaction is not specific for pregnanediol; many other 
steroids give similar colours with varying intensities. The specificity of the method as 
a whole therefore depends upon the completeness with which other chromogenic 
steroids originally present in the urine are eliminated in the extraction and purification 
process.. 
Some data relevant to this extremely important point have been presented by 
previous workers. Thus Astwood & Jones [1941] showed that cholesterol and andro- 
sterone were completely eliminated by their double precipitation process when 
present in amounts not exceeding 16 and 8 mg. per litre respectively, while Talbot 
et al. [1941] showed that dehydroisoandrosterone in amounts up to c. 10 mg. per litre 
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caused no interference. In the course of present work additional relevant data have 
been accumulated, but since these data are still incomplete they will be referred to at 
the present time only briefly. 
Androsterone, isoandrosterone, and pregnan- 3(a) -o1 -20 -one are not completely 
eliminated by the triple precipitation process -used, but providentially they are so 
much less powerfully chromogenic than pregnanediol in the sulphuric acid reaction 
that their presence in the.final product, except in abnormally large amounts, does not 
introduce any serious error into the pregnanediol determination. Dehydroiso- 
androsterone and pregnane -3(a), 17, 20- triol, on the other hand, are very powerful 
chromogens, but, providentially again, they seem to be very readily eliminated in the 
precipitation process. Any possible interference by the pregnanetriol is doubly safe- 
guarded against by the fact that this compound would be largely decomposed during 
the initial hydrolysis of the urine with acid. 
These preliminary findings provide hope that the method may be reasonably 
specific for pregnanediol when applied to normal urines, but before definitely con- 
cluding that it is indeed so it will be necessary to carry out further experiments with 
other steroids likely to be present. At the present time the method cannot be recom- 
mended for pathological urines containing abnormally high concentrations of neutral 
17- ketosteroids or of other neutral steroids of adrenal origin. In such cases the preg- 
nanediol present might be considerably overestimated. In passing, it may be re- 
marked that any of the methods in which pregnanediol is determined as its glucuronide 
are also likely to give fictitiously high results when applied to urines containing 
abnormally high concentrations of steroids of adrenal origin, since certain of the latter 
are probably excreted as glucuronides also. 
DISCIISSION 
The methods of urinary pregnanediol determination which have hitherto been 
described are either insufficiently sensitive or insufficiently specific to permit of 
strictly quantitative studies being carried out upon pregnanediol excretion during the 
menstrual cycle and during the early stages of pregnancy. The method described here 
should make such studies more nearly possible, and in particular should be of some 
value in the investigation of causes of female sterility. 
Although the method was not designed for use as a means of pregnancy diagnosis, it 
may be useful for this purpose, and because of its more quantitative nature it may 
prove to be less subject to both positive and negative errors than the more rapid 
Guterman [1944, 1945] method. In view of the widespread interest in the latter it 
would perhaps not be out of place to discuss in the light of the findings in the present 
work some of the possible sources of the negative and positives errors to which the 
method seems to be subject [cf. Reinhart & Barnes, 1946]. 
In his latest paper on the method Guterman [1945] has arbitrarily fixed on an 
intensity of colour in the sulphuric acid reaction corresponding to 6-8 mg. of preg- 
nanediol per 24 hr. as the lower limit for a positive reaction. It seems probable that at 
such levels of pregnanediol excretion the unsatisfactory cooling conditions in the 
precipitation process in Guterman's procedure might lead to low and variable yields of 
pregnanediol and thus to false negative results. It is likely that a controlled slow 
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cooling ' technique in the precipitation process might eliminate some at least of these 
false negatives. 
The findings in the present work suggest that false positives might be caused by the 
presence of abnormally large amounts of the weakly chromogenic saturated neutral 
17- ketosteroids which are incompletely removed even by a triple precipitation 
procedure, or by the incomplete elimination in the single precipitation of the Guterman 
method of the strongly chromogenic dehydroisoandrosterone. In this connexion it is 
noteworthy that Morrow & Benua [1946] recorded false positives in a case of arrheno- 
blastoma which was excreting 59 mg. of 17- ketosteroids per 24 hr. It is doubtful 
whether false positives caused by the presence of abnormally large amounts of 17- 
ketosteroids could be entirely eliminated by any simple modification in the pre- 
cipitation process, but it is likely that their number could be reduced if a double 
instead of a single precipitation procedure were to be adopted. 
In conclusion, one may perhaps question whether it is justifiable to accept as 
diagnostic of pregnancy. any arbitrarily fixed low level of pregnanediol excretion 
associated with amenorrhea. It must be remembered that little is known at the present 
time about the metabolism .of progesterone, and there are in fact few reasons to 
believe that pregnanediol is even the main metabolic end- product of the latter. The 
low yields of urinary pregnanediol obtained after the administration to human 
subjects of progesterone raise the possibility that the latter may be largely meta- 
bolized in the body by other routes. It is therefore questionable whether the level 
of pregnanediol excretion provides a reliable indication of the progesterone production 
in the body, as has been so widely assumed. 
As pointed out by Reinhart & Barnes [ 1946], it is possible that the greatest source of 
error in the Guterman test is the `individual variations in the metabolism of pro- 
gesterone, both in the pregnant and the non -pregnant woman'. 
SUMMARY 
A procedure based on the methods of Astwood & Jones [1941] and Talbot et al. [1941] 
has been elaborated which permits of the reasonably accurate determination of more 
than c. 0.4 mg. of pregnanediol in a fifth of a 24 hr. sample of human urine. 
This work was carried out at the request of the Committee on Human Fertility of 
the Medical Research Council. The authors are indebted to the Medical Research 
Council for a grant from which the expenses of the work were defrayed and for personal 
grants to two of them (N.G. and I.F.S.). They are also indebted to their colleagues who 
co- operated in the collection of urine and to Miss E. Sutherland who prepared the 
sample of pure sodium pregnanediol glucuronidate. 
Part of this work 'was carried out by I.F.S. during the tenure of a Vans Dunlop 
Scholarship in the Department of Obstetrics and Gynaecology. 
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THE Guterman (1944, 1945) qualitative test for 
urinary pregnanediol, based on the quantitative procedure 
developed by Astwood and Jones (1941) and Talbot et al. 
(1941), has been widely used for the early diagnosis of 
pregnancy and for prognosis in threatened abortion. 
Though there is some measure of agreement that the 
method may be useful in the prognosis of threatened 
abortion (Guterman 1946, Bender 1947, 1948, Merivale 
1948), opinions on its value in the diagnosis of pregnancy 
are sharply divided. Guterman (1944, 1945) and 
McCormack (1946) have claimed an accuracy as great 
as that of the Friedman method ; on the other hand, 
Reinhart and Barnes (1946) and Merivale (1948) have 
reported high percentages of both false positives and 
false negatives. In our opinion their unsatisfactory 
results are possibly due partly to technical deficiencies 
of the method, some of which are avoidable. 
The Guterman test depends on the detection, by means 
of a colour reaction with sulphuric acid, of an amount 
of pregnanediol in 100 ml. of morning urine which is 
stated to correspond approximately to an excretion of 
6 -8 mg. of the steroid per 24 hours. Guterman considers 
a pregnancy test to be positive if this amount of 
pregnanediol or more is detected in the urine during 
amenorrhoea. Morrow and Benua (1946) have, however, 
observed " false positive tests for pregnancy " in the 
luteal phase of the menstrual cycle, and have pointed out 
that, since there may be a considerable overlap between 
the lower levels of pregnanediol excreted during early 
pregnancy and the higher Ievels excreted during the 
latter half of the menstrual cycle, there is a danger of 
obtaining false positive reactions in cycles prolonged by 
late ovulation. This criticism seems to be valid ; but, 
provided no reliance is placed on positive reactions obtained 
within a short time of an apparently missed period, 
the danger of diagnosing a delayed or prolonged luteal 
phase of the cycle as a pregnancy should not be serious. 
Reinhart and Barnes (1946) criticise the method on 
rather similar grounds, pointing out that " a test which 
is not accurate in the face of vaginal bleeding is of 
restricted value as a diagnostic aid in hospital practice." 
Though this is doubtless true, we feel that their further 
statement that " the source of error lies not in the 
interpretation of the colour reaction but in individual 
variations in the metabolism of progesterone, both in the 
pregnant and the non -pregnant woman " cannot pass 
unchallenged. They seem to have overlooked the 
possibility .that a not inconsiderable source of both 
positive and negative errors may lie in the technique of 
the stages in the method preceding the final colour 
assessment, and it is at least possible that they have 
over -emphasised the importance of individual variations 
in progesterone metabolism. The methods hitherto 
used for studying the excretion of pregnanediol during 
the menstrual cycle and early pregnancy are insufficiently 
accurate to show whether there are considerable individual 
variations in the extent to which progesterone is reduced 
to pregnanediol in non -pregnant and pregnant women. 
A general criticism that can be justifiably made of 
the Guterman method is that a quantitative significance 
has been attached to the results of a qualitative test. 
Attempts have been made by several workers to make the 
test quantitative rather than qualitative by examining 
the colour spectrophotometrically instead of visually. 
Such attempts, however, must necessarily fail in their 
object, since the test is carried out on an unknown 
fraction of the 24 -hour urine output, and since, as 
recently shown by Sommerville et al. (1948), the pro- 
cedure used for purifying the extracted pregnanediol 
is likely to give low and erratic results when applied to 
urine containing less than about 20 mg. of the steroid 
per 24 hours. 
It seems clear that the value of pregnanediol determina- 
tions for diagnosis requires careful reinvestigation with 
the aid of a method more nearly quantitative and less 
open to criticism on technical grounds than is the 
Guterman procedure. The method of Sommerville 
et al. (1948), which has been shown to be reasonably 
accurate at - levels of pregnanediol * excretion above 
about 2 mg. per 24 hours, would be suitable for such an 
investigation but is somewhat too laborious and time - 
consuming for routine use. Accordingly an attempt 
has been made to develop a procedure combining the 
speed and simplicity of the Guterman method with 
certain of the technical improvements made in the 
original Astwood and Talbot procedures by Sommerville 
et al. (1948). The method developed permits of the 
reasonably accurate quantitative determination in less 
than 3 hours of the pregnanediol in 100 ml. of urine, 
provided that the level of excretion is above about 
5 mg. per 24 hours. It will probably be less liable than 
the Guterman method to give erratic results at low 
levels of pregnanediol excretion, but like the latter it 
Unpublished work by Sommerville and Marrian has shown that 
allopregnane -3(a), 20a -dio1, as well as pregnane -3(a), 20a -diol, 
is determined by this method. In this paper the term 
" pregnanediol " is used to designate the mixture of both 
stereoisomers that is present in urine. 
DETERMINATION OF URINARY PREGNANEDLOL 
Recovery of pregnane -3(a), 20a -diol added to men's urine 
after acid hydrolysis 
Urine Pregnanediol added (mg.) 
Pregnanediol recovered corrected 
for average male urine blank (mg.) 
Per 100 
ml. urine 
Per 24 hrs. 
urine 
Per 100 ml. 
urine 




A - - 0.01 ay. 0.17 ay. - - 0.02) 0',25 023 
B - - 0.02 ay. 0.27 ay. - - 0.03 02 0.54 0.40 .. - - 0.02 0.40 
A 0.2 2.8 0.10 1.3 48 
0.05 0.71 26 
0.06 0.88 32 
B 99 3.6 0.17 3.1 87 
Pt sp 0-19 3.4 94 
B 0.3 5.4 0.31 5.5 102 
99 0.25 4.5 83 
0.28 5.2 94 
A 0.4 5.6 0.28 3.9 70 
SS PP 0.24 3.3 60 
0.34 4.7 85 
B 0.4 7.2 0.35 6.3 88 
0.34 6.1 85 
. 0.39 7.0 98 
A 0,, 8.4 




B 0.5 9.0 0.41 7.3 82 
0.45 8.1 90 
will be likely to give fictitiously high results when applied 
to- urine containing an abnormally high amount of 
cholesterol or of neutral 17- ketosteroids. This method 
is only recommended for routine diagnostic purposes 
where a high degree of accuracy and great sensitivity 
are not essential ; for quantitative studies of pregnanediol 
excretion during the menstrual cycle or early pregnancy 
the longer method of Sommerville et al. (1948) would 
be preferable. 
METHOD 
Into a 500 ml. flask fitted with an interchangeable 
ground -glass joint and a reflux condenser is placed 100 ml. 
of a 24 -hour urine specimen, the volume of which is 
measured, and 50 ml. of toluene (" sulphur- free," 
redistilled). The contents are heated to boiling and, after 
the addition of 10 ml. of concentrated hydrochloric 
acid (A.R. quality), the boiling is continued for exactly 
10 min. The mixture is cooled, transferred to a 250 ml. 
separating funnel, and shaken. After standing for 
about 5 min, the lower urine layer is run off and dis- 
carded, and the upper toluene emulsion layer is filtered 
through a Buchner funnel with gentle suction, a Whatman 
no. 1 paper being used to break the emulsion. The 
filtrate is then transferred back into the separating 
funnel, and the lower urine layer that separates from the 
emulsion is run off and discarded. 
The toluene layer is washed in.the funnel twice with 
15 ml. lots of Nil NaOH and twice with 15 ml. lots of 
water. It is then transferred to a 200 ml. round -bottomed 
flask fitted with a bent ground -glass " socket adapter " 
(Quickfit and Quartz Ltd.) and evaporated to dryness 
under reduced pressure in a boiling water -bath. 
The residue in the flask is quantitatively transferred 
with warm ethyl alcohol to a test -tube (1 in. diam.) 
which has a graduation mark at the 5 ml. level. The 
solution is then evaporated to 5 ml. in a warm water - 
bath under a gentle stream of air. After the tube has 
been placed in a beaker of water at 75 °C, 20 ml. of 
N /10 NaOH is added slowly from a burette over a period 
of 3 min. and stirred gently with a glass rod. After a 
further minute the beaker and tube are transferred to 
an incubator at 37 °C and left for 2 hours. 
The contents of the tube are then filtered through 
a sintered glass funnel (3 cm. dram. plate ; average 
por. diam. 20 -30 u), the tube and filter being sub- 
sequently washed liberally with water to remove all 
traces of alkali from the precipitate. The funnel is 
removed from the filter flask and fitted to a test- 
tube (1 in. dram.) with a side -arm. The precipitate is 
then washed through into the tube with three 5 ml. 
lots of boiling alcohol under gentle suction. 
To the filtrate in the filter -tube is added about 1 -2 mg. 
of ` Norit ' charcoal, and the mixture is heated in a 
water -bath for 2 min. and filtered through a Whatman 
no. 1 paper in a conical filter (2 in. diam.) into a test - 
tube (1 in. diam.). The filtrate is finally evaporated to 
dryness in a water -bath under a stream of air. 
2 
To the dry residue in the tube is added 10 ml. of 
concentrated sulphuric acid (A.R. quality). The tube 
is placed in a constant temperature bath at 25 °C and 
left for 20 min. with occasional shaking. The intensity 
of the yellow colour produced is then measured in a 
` Spekker ' photo -electric absorptiometer using a ` spec- 
trum violet ' no. 601 light filter. The absorptiometer 
readings are interpreted by reference to a calibration 
curve made with known amounts of pure pregnane- 
3(oc), 20a -diol, and the final result is expressed as mg. 
of pregnanediol excreted per 24 hours. The calibration 
curve should be checked at short intervals. 
RESULTS 
Urine Blanks. -Blank determinations in triplicate were 
carried out on eight 100 ml. samples from 24 -hour urine 
specimens collected from seven different normal men. 
The values for " apparent pregnanediol " excreted per 
24 hours varied from 0.13 to 0.61 mg. Though 
pregnanediol has been reported to be present in small 
amounts in men's urine (Westphal 1944), there are reasons 
for believing that these small urine blank values are 
largely due to chromogenic substances other than 
pregnanediol which are incompletely removed in the 
precipitation procedure. However, the highest of these 
blank values is so much smaller than the lowest amount 
of pregnanediol that can be estimated with any degree 
of accuracy that errors due to this cause may be neglected. 
Recovery Experiments. -Two 24 -hour urine specimens 
(A and B) were collected on successive days from the 
same normal man. Twelve 100 ml. samples were taken 
from specimen A and fifteen from B. After hydrolysis 
of these with hydrochloric acid, amounts of pure 
pregnane -3(a), 20a -diol varying from 0.2 to 0.6 mg. 
were added in alcoholic solution, three samples from 
each specimen being reserved as triplicate blanks. The 
pregnanediol in each sample was then determined by the 
method described, and the recoveries calculated after 
correcting for the appropriate blank. The results (see 
table) show that satisfactory recoveries were obtained 
with amounts of pregnanediol corresponding to more 
than about 5 mg. per 24 hours. 
We are indebted to the Medical Research Council for a 
personal grant to one of us (I. F. S.) and for a grant (to 
G. F. M.) out of which part of the expenses of this work were 
defrayed ; and to Mr. D. C. Parkes for much skilful technical 
assistance. 
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THE proposal of Smith et al. (1946) to give diethylstilb- 
cestrol by mouth as a prophylactic to pregnant women 
with histories of repeated accidents in pregnancy has 
attracted widespread interest, particularly in connexion 
with the high foetal mortality associated with maternal 
diabetes. This proposal is based on the suppositions that 
many accidents of late pregnancy are referable to a 
deficiency in the secretion of progesterone and other sex 
steroids by the placenta, and that the secretion of these 
steroids can be stimulated with diethylstilbcestrol. The 
second of these suppositions is based on the interesting 
théories concerning the interdependence of oestrogen and 
progesterone metabolism, developed by the Smiths in 
a long series of papers published from 1931 onwards and 
recently reviewed (Smith and Smith 1948). 
The Smiths believe (1) that the oestrogenic hormone 
( oestradiol eestrone) is converted in the body not only 
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byilitating the metabolism of oestradiol and ces row 
by the alternative pathway to oestriol, and conversely 
that the formation of the inactivation products is 
enhanced when there is a deficient secretion of proges- 
terone ; and (3) that the oestrogen inactivation products 
play an important physiological rôle as stimulators of 
the secretion gf progesterone and other " sex steroids." 
These views led Smith et al. (1944) to suggest that 
massive doses of the oestrogenic hormone during mid - 
pregnancy might forestall an incipient premature 
deficiency in the secretion of progesterone and oestrogen 
from the placenta by raising the concentration in the body 
of these oestrogen inactivation prodúcts. 
Later Smith et al. (1946) suggested that the artificial 
oestrogen, diethylstilbcestrol, might be more effective in 
stimulating the placental secretion of steroids, and they 
tried to test this suggestion by estimating the urinary 
pregnanediol excretion of a pregnant diabetic woman 
during intermittent treatment with this oestrogen. The 
results seemed to show conclusively that the excretion 
of pregnanediol had been increased by the diethyl- 
stilbcestrol,* and it was concluded that this increase was 
the result of a greater placental secretion of progesterone. 
More recently some doubt on their findings has been 
cast by Davis and Fugo (1947), who claimed that the 
excretion of pregnanediol by non - diabetic women in 
early pregnancy was unchanged by treatment with 
diethylstilbcestrol. This claim calls for some comment. 
The published data show that no pronounced and 
progressive rise in the excretion of pregnanediol, like 
that observed by Smith et al. (1946), resulted from the 
treatment ; but, since the pregnanediol excretion levels 
before treatment with the oestrogen were not established 
with certainty, the statement that the pregnanediol 
excretion was unchanged hardly seems justifiable. In 
any case, as Smith and Smith (1948) pointed out, the 
doses of diethylstilbcestrol used by Davis and Fugo 
were greatly in excess of those used by themselves ; 
hence the two sets of experiments are hardly comparable. 
We report here the results of a reinvestigation of the 
effect of diethylstilbcestrol on the urinary excretion of 
pregnanediol during pregnancy. Since the Smiths' 
nrshe has obtained similar results with 
ono 
therf pregnant diabetic 




theories imply that diethylstilbcestrol stimulates the 
secretion of oestrogen as well as. of progesterone by 
the placenta, the urinary: excretion of endogenous 
oestrogen has also been studied in these experiments. 
METHODS 
Daily 24 -hour specimens of urine were collected in con- 
tainers cooled with " dry ice " from all the cases studied. 
In most instances the completeness of the collection of 
urine was checked by determining the creatinine 
content by the method of Folin (1914). All deter- 
minations were carried out in duplicate on aliquot 
portions of the 24 --hour specimens of urine. 
Urinary pregnanediol was determined by the method 
of Sommerville et al. (1948). 
Total urinary endogenous oestrogen (cestradiol+ 
cestrone+cestriol) was determined by the method of . 
Stevenson and Marrian (1947) using the Kober colour 
reaction, which is unaffected by the presence of diethyl - 
stilbcestrol in the urine. This method, though not so 
reliable as could be desired, is sufficiently accurate 
to detect any pronounced changes in the excretion 
of endogenous oestrogen. 
RESULTS 
One non -diabetic pregnant woman and .three 
diabetic pregnant women were studied. The 
essential clinical points of the diabetics, for which 















History of previous pregnancies 
- 
Intra- uterine death 3 days ante - 
partum 
(i) Intra- uterine death 5 days 
antepartum 
(ii) Miscarriage at 19th week 
Doses of diethylstilbcestrol greater than, less than, and 
the same 
as, those recom- 
mended 
by Smith et 
al. (1946) 
6 
were given 4 
by mouth 
intermit- 2 tently. 
Smith et al. recom- 
mended 
a dosage of 
30 mg. daily at t h e 
beginning 




by 5 mg. a 
















s t it b cestrol 
dosages and 
of t h e effects 
on t h e 
excretion of pregnanediol and endogenous cestrogen 
are shown in figs. 1 -5,t from which it will be seen that 
the effect 'of diethylstilbcestrol on the urinary excretion 
of pregnanediol ' is unequivocal. In every instance 
t The values obtained in the duplicate determination of preg- 
nanediol and oestrogen are shown by the double lines at the - 
tops of the columns in each figure. 
DIETHYLST LBCESTROL(daily) 
30 mq. 
A....... .,: ......: :..A 
18 th WEEK 20th WEEK 22nd 
WEEK 
Fig. 3-Effect of diethylstilbcestrol on excretion 
of pregnanediol and endogenous cestrogen in a 
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DIETHYLSTILBíESTROL (daily) 
50 mg. 50 mg. 
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theories imply that diethylstilbcestrol stimulates the 
secretion of oestrogen as well as: of progesterone by 
the placenta, the urinary excretion of endogenous 
oestrogen has also been studied in these experiments. 
METHODS 
Daily 24 -hour specimens of urine were collected in con- 
tainers cooled with " dry ice " from all the cases studied. 
In most instances the completeness of the collection of 
urine was checked by determining the creatinine 
content by the method of Folin (1914). All deter- 
minations were carried out in duplicate on aliquot 
portions of the 24 =hoiir specimens of urine. 
Urinary pregnanediol was determined by the method 
_ of Sommerville et al. (1948). 
Total urinary endogenous oestrogen (cestradiol+ 
cestrone+cestriol) was determined by the method of . 
Stevenson and Marrian (1947) using the Kober colour 
reaction, which is unaffected by the presence of diethyl - 
stilboestrol in the urine. This method, though not so 
reliable as could be desired, is sufficiently accurate 
to detect any pronounced changes in the excretion 
of endogenous oestrogen. 
RESULTS 
One non- diabetic pregnant woman and three 
diabetic pregnant women were studied. The 
essential clinical points of the diabetics, for which 
we are indebted to Prof. D. M. Dunlop, were as follows : 
Case Age Duration of (yr.) diabetes History of previous pregnancies 
1 30 Since childhood - 
2 30 2 years Intra- uterine death 3 days ante- 
partum 
3 30 11 years (i) Intra- uterine death 5 days 
antepartum 
(ii) Miscarriage at 19th week 
Doses of diethylstilbcestrol greater than, less than, and 
the same 
as, those W recom- -- mended tir 
by Smith et y Ñ 
6 
al. (1946) ,z 
were given j a 4 
by mouth 2 É intermit- 0'- 2 tently. pp 
Smith et al. W o recom- 26 
mended 
a dosage of --, 24 
30 mg. daily at the Ñ22 beginning 
of the 16th 




14th WEEK 15th WEEK 
Fig. I- Effect of diethylstilbestrol 
on excretion of pregnanediol and 
endogenous estrogen in a normal 
pregnant woman. 
14th WEEK I6thWEEK 
Fig. 2- Effect of diethylstilbestrol 
on excretion of pregnanediol and 
endogenous estrogen in a diabetic 
pregnant woman (case I). 
into cestriol but also into certain estrogenically inactive 
oxidation products, which, however, have yet to be 
isolated and described ; (2) that progesterone depresses 
the formation of these " oestrogen inactivation products " 
by facilitating the metabolism of estradiol and oestrone 
by the alternative pathway to oestriol, and conversely 
that the formation of the inactivation products is 
enhanced when there is a deficient secretion of proges- 
terone ; and (3) that the oestrogen inactivation products 
play an important physiological rôle as stimulators of 
the secretion of progesterone and other " sex steroids." 
These views led Smith et al. (1944) to suggest that 
massive doses of the oestrogenic hormone during mid - 
pregnancy might forestall an incipient premature 
deficiency in the secretion of progesterone and oestrogen 
from the placenta by raising the concentration in the body 
of these oestrogen inactivation products. 
Later Smith et al. (1946) suggested that the artificial 
(estrogen, diethylstilbcestrol, might be more effective in 
stimulating the placental secretion of steroids, and they 
tried to test this suggestion by estimating the urinary, 
pregnanediol excretion of a pregnant diabetic woman 
during intermittent treatment with this oestrogen. The 
results seemed to show conclusively that the excretion 
of pregnanediol had been increased by the diethyl- 
stilbcestrol,* and it was concluded that this increase was 
the result of a greater placental secretion of progesterone. 
More recently some doubt on their findings has been 
cast by Davis and Fugo (1947), who claimed that the 
excretion of pregnanediol by non - diabetic women in 
early pregnancy was unchanged by treatment with 
diethylstilbestrol. This claim calls -for some comment. 
The published data show that no pronounced and 
progressive rise in the excretion of pregnanediol, like 
that observed by Smith et al. (1946), resulted from the 
treatment ; but, since the pregnanediol excretion levels 
before treatment with the oestrogen were not established 
with certainty, the statement that the pregnanediol 
excretion was unchanged hardly seems justifiable. In 
any case, as Smith and Smith (1948) pointed out, the 
doses of diethylstilbestrol used by Davis and Fugo 
were greatly in excess of those used by themselves ; 
hence the two sets of experiments are hardly comparable. 
We report here the results of a reinvestigation of the 
effect of diethylstilbcestrol on the urinary excretion of 
pregnanediol during pregnancy. Since the Smiths' 
Dr. O. Vi. Smith has privately informed one of us (G. F. M.) that 
she has obtained similar results with other pregnant diabetic 
women treated with diethylstilbcestrol. 
increasing ó 18 
by 5 mg. a 
W day at = 16 weekly 
intervals to 14 






o f t h e effects 
o n t h e 
DIETHYLSTILBO=STROL (daily) 
30 ma. 
18 th WEEK 201hWEEK 22nd 
WEEK 
Fig. 3-Effect of diethylstilbestrol on excretion 
of pregnanediol and endogenous oestrogen in a 
diabetic pregnant woman (case 2). 
excretion of pregnanediol and endogenous oestrogen 
are shown in figs. 1 -5,t from which it will be seen that 
the effect of diethylstilbestrol on the urinary excretion 
of pregnanediol is unequivocal. In every instance 
t The values obtained in the duplicate determination of preg- 
nanediol and oestrogen are shown by the double lines at the- 
tops of the columns in each figure. 
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the giving of diethylstilbcestrol caused a sharp 
fall in the excretion of pregnanediol, whereas 
after withdrawal of the oestrogen the excretion 
rose either immediately or after á short delay. 
The figures for the excretion of total endo- 
genous oestrogen are unfortunately less clear -cut 
owing possibly to the known unreliability of the 
method of estimating oestrogen. It can be safely 
stated, however, that in these experiments the 
giving of diethylstilboestrol caused no gross change 
in the excretion of total endogenous oestrogen. 
DISCUSSION 
The discrepancy between the results reported 
by Smith et al. (1946) and those reported here 
may possibly be due to the different methods used 
for the estimation of pregnanediol. The method 
of. Sommerville et al. (1948), used in the,present 
work, gives satisfactorily accurate and repro- IO 
ducible results when about 2 mg. of pregnanediol 
is excreted per 24 hours, and there is good reason 
to believe that it is reasonably specific for 
pregnanediol and allopregnanediol. There can 
be little doubt, therefore, . that the reduction in preg- 
nanediol excretion following treatment with diethyl - 
stilboestrol reported here was genuine. 
Smith et al., on the other hand, used the original 
Venning (1937, 1938) method, which, it is now known, 
is not highly specific for pregnanediol. In this method 
sodium pregnanediol glucuronidate is extracted from the 
urine and weighed after " purification," the purity of 
the final product being checked by determining its 
melting- point. Unfortunately, however, the melting - 
poïnt of sodium pregnanediol glucuronidate is unsatis- 
factory as a criterion of its purity. The compound 
decomposes at its melting- point, and this decomposition 
point may be affected to a relatively small extent by the 
presence of considerable amounts of other related sub- 
stances. In actual fact Strickler et al. (1943), Mason and 
Kepler (1945), and Marrian and Gough (1946) have 
shown that the " purified " sodium pregnanediol glucu- 
ronidate fraction prepared from human urine by the 
Yenning method may contain considerable amounts of 
the sodium glucuronidates of substances other than 
pregnanediol. 










25 mg. 50 mg. 
i 
20 th WEEK 22nd WEEK 24th WEEK 26thWEEK 
Fig.5- Effect of diethylstilboestrol on excretion of 
pregnant woman. 
DIET HY LSTI LBO=STRO L (daily) 
25 mg. 30 mg. 
14 th WEEK 16 th WEEK 18 th WEEK 
Fig. 4 -Effect of diethylstilbces rol on excretion of pregnanediol and 
endogenous ces'roeen in a diabetic pregnant woman (case 3). 
pregnanediol in a normal 
excretion following the administration of diethylstilb- 
oestrol reported by Smith et al. (1946) may well have 
been due to the excretion of substances related to, but 
not identical with, sodium pregnanediol glucuronidate. 
In this connexion it should be pointed out that Dodgson 
and Williams (1948) have demonstrated the presence of 
a glucuronide of diethylstilboestrol in human urine after 
the administration of diethylstilbcestrol by mouth. The 
possibility cannot be dismissed, therefore, that the 
results of Smith et al. were affected by the contamination 
of the sodium pregnanediol glucuronidate isolated by 
sodium diethylstilboestrol glucuronidate. 
Knowledge of the metabolism of progesterone is as 
yet so incomplete that it should not be assumed that 
changes in the excretion of pregnanediol in the urine 
necessarily reflect changes in the secretion of endogenous 
progesterone. 
SUMMARY 
The administration of diethylstilbcestrol by mouth to 
diabetic and normal pregnant women causes a sharp fall 
in the urinary excretion of pregnanediol. Withdrawal of 
the diethylstilbcestrol results in a rise in pregnanediol 
excretion, either immediately or after a short delay. 
These results differ from those reported by Smith et al. 
(1946). 
The administration of diethylstilboestrol causes no 
gross change in the excretion of endogenous oestrogen in 
diabetic and normal pregnant women. 
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